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Abstract
The overall aim of the work presented in this thesis is to better understand the molecular
mechanisms underlying the progression of the meiotic division in mammalian oocytes.
The first goal of this project was to investigate the relative contribution of securin and
cyclin B1 to the control of the protease separase during the indeterminate period of
metaphase II arrest. I found here that although there are conditions in which either
securin or MPF can prevent chromosome disjunction, such as during meiosis I, securin is
the predominant inhibitor of separase during metaphase II arrest. Thus, CDK1
pharmacological inhibition as well as antibody inhibition of CDK1/cyclin B1 binding to
separase, both failed to induce sister chromatid disjunction. Instead, securin morpholino
knockdown induced sister chromatid separation, which could be rescued by injection of
securin cRNA.
I also examined the effect of CDK1 and MAPK activities on securin stability. Inhibition
of both kinases, but not either one alone, using roscovitine and UO126, induced the
premature destruction of securin during prometaphase of meiosis I. However, this effect
is not dependent on securin phosphorylation, given that mutagenesis of CDK1 and
MAPK phosphorylation sites on securin did not affect its stability.
Finally, I found that CDK1 and MAPK inhibition also causes the premature degradation
of other APC/C substrates, such as cyclin B1 and geminin. Interestingly, only the D-box3
containing substrates and not Ken-box substrates were subject to such effect. However,
this prometaphase I instability of the D-box substrates was apparently not mediated by
APC/C
Cdc20 or APC/C
Cdh1, given that Cdc20 was also targeted for destruction and
morpholino-knockdown of both Cdc20 and Cdh1 failed to rescue securin stability. Also,
the inhibition of SCF
-TrCP using the dominant negative mutant of its F-box protein (-
TrCP) could not restore securin levels, suggesting it is not SCF
-TrCP-dependent. Future
work will explore whether this effect could be attributed to activation of some meiosis-
specific APC/C co-activators or the core APC/C, which was recently reported of being
able to directly interact with the D-box containing substrates independently of Cdc20 and
Cdh1 (Passmore et al., 2003; Yamano et al., 2004).4
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Chapter 1: General introduction
Sexual reproduction is the creation of new offspring by the fusion of haploid gametes to
form a diploid zygote. Gametes are generated from diploid primordial germ cells (PGC)
by the process of meiosis. The female gamete is usually large and non-motile and is
referred to as the egg (or ovum) (AUSTIN and Short, 1993). The male gamete, however,
is small and motile and is referred to as the sperm (or spermatozoon) (AUSTIN and
Short, 1993). Sexual reproduction has been favoured by evolution because it increases
genetic diversity among offspring and generates individuals with unique assortments of
genes inherited from both parents, therefore enhancing the reproductive success of
parents and the survival of offspring (Alberts et al., 2000; Campbell et al., 1999).
The experiments presented in this thesis investigate part of the regulatory mechanisms
underlying the progression of the meiotic division in mammalian oocytes. In order to
introduce the research presented here, I will first provide an overview of meiosis, the
process through which the haploid gametes are formed. Then, I will consider all the
events that give rise to the fully-grown female gamete (the unfertilized egg) as well as the
process of fertilization. Finally, I will provide a detailed description of the current
understanding of how the meiotic cell divisions are controlled and how the oocyte
segregates its chromatin in the first and second meiotic divisions.15
1.1. Overview of meiosis
The finding that gametes are haploid in chromosome number and DNA content, a state
that must therefore be achieved through cell divisions of an unusual kind, came from the
discovery that the roundworm gametes contain only 2 chromosomes, whereas the zygote
(the fertilized egg) contains 4 chromosomes (Van Beneden, 1883). This special type of
cell division is called meiosis, from the Greek meaning diminution (Alberts et al., 2000;
Van Beneden, 1883).
Meiosis is a unique process by which diploid germ cells (oogonia and spermatogonia)
reduce their chromosome number by half, therefore allowing a diploid number of
chromosomes to be reinstated at fertilization (AUSTIN and Short, 1993). It consists of a
single phase of DNA replication followed by two consecutive rounds of division, called
meiosis I (MI) and meiosis II (MII). During the first meiotic cell division, both the DNA
content and chromosome number is halved, through the segregation of the two replicated
homologs into separate daughter cells. In the second meiotic division, however, only the
DNA content is halved via the separation of the sister chromatids (AUSTIN and Short,
1993).
Both meiotic divisions are divided into prophase, metaphase, anaphase and telophase,
which are identical in purpose to their analogous mitotic sub-phases. Meiotic prophase I,
however, lasts longer and is more complex than the prophase of the mitotic cell cycle
(Alberts et al., 2000). It is characterised by the pairing of the two replicated homologs, a
process called synapsis, and the crossing over of non-sister chromatids leading to16
formation of chiasmata, which play a crucial role in holding homologous chromosomes
together during metaphase of the first meiotic division (Met I), therefore ensuring their
accurate segregation during anaphase I (Campbell et al., 1999). Chiasmata are also
important in rearranging genes via DNA exchange between the homologous
chromosomes. This is achieved during the process of homologous recombination, which
is initiated by the genetically programmed formation of double-strand breaks, hence
triggering the equivalent of DNA-damage repair using the homologous chromosome as a
template (Campbell et al., 1999). During this repair process, DNA can be exchanged
between the homologous chromosomal regions, leading to new combinations of DNA
within the chromosomes (Campbell et al., 1999). In some cases, no exchange happens
and the DNA is transferred from one helix, which remains unaltered, to the other helix,
therefore leading to gene conversion, which plays an important role in gene mutagenesis
and non-Mendelian inheritance (Campbell et al., 1999).
1.2. The mammalian ovum
The mammalian ovum, or egg, is a particularly fascinating cell, as it is the cell from
which all the cells in a new organism are derived. As the sperm contributes virtually
nothing to the new organism other than its chromosomes, the ovum has the difficult task
of supplying most of the material for the body of the embryo and providing for its
protection and maintenance during development (Campbell et al., 1999; Wilson, 1925).
In order to prepare for this service, the ovum goes through an extensive period of growth
during which it accumulates a large amount of cytoplasm, and in many cases becomes17
surrounded by membranes or other protective envelopes (Campbell et al., 1999; Wilson,
1925).
1.2.1. The structure of the mammalian ovum
The mammalian egg is structurally specialised for fertilization. It consists of a spherical
mass of cytoplasm, which is bounded by a plasma membrane and enclosed within a thick
glycoprotein envelope called the zona pellucida (ZP) (Bleil and Wassarman, 1980;
Dunbar et al., 1994). Beyond the zona pellucida, the egg is surrounded by a matrix of
granulosa cells, called the cumulus oophorus. The oocyte and granulosa cells are
interconnected via gap junctions, which are crucial in the maturation process of the
oocyte through metabolites and regulatory elements transfer between the two cell types
(Anderson and Albertini, 1976; Heller et al., 1981). Between the plasma membrane and
the zona pellucida is a fluid-filled space, the perivitelline space. Lying immediately
beneath the plasma membrane is a thin shell of actin-rich cytoplasm called the cortex.
Within the cortex are the cortical granules, which contain proteolytic enzymes and
mucopolysaccharides. These Golgi-derived structures play a crucial role in the egg’s
response to sperm penetration, especially preventing the entry of more than one
spermatozoon (polyspermy) (Barros and YANAGIMA.R, 1971; Gwatkin et al., 1973).
1.2.2. Oogenesis: from primordial germ cells to eggs
The process of gametogenesis in the female is known as oogenesis, and a developing egg
is called an oocyte (AUSTIN and Short, 1993). Unlike spermatogenesis, which is18
initiated in puberty and continues throughout the male adult life, oogenesis begins during
female embryonic life and ends months to years later in the sexually mature adult
(AUSTIN and Short, 1993). The details of oogenesis (timing of events) are different
between species, but the general stages are the same.
In mammals, oogenesis starts with the mitotic proliferation of the diploid primordial
germ cells, as they migrate to the developing ovary to become oogonia (Bukovsky et al.,
2005). Once they arrive to the gonads, the diploid oogonia begin to differentiate into
primary oocytes (Bukovsky et al., 2005). At this stage, the oocytes enter meiosis, and
become arrested in prophase of the first meiotic division for a period lasting from few
months (mice) to many years (humans), until the female becomes sexually mature at
puberty (Alberts et al., 2000; Bukovsky et al., 2005; Wolpert et al., 1998). After entry
into meiosis, the oocytes never proliferate again, therefore, the number of oocytes at this
embryonic stage is the total number of eggs the female mammal will ever have (Wolpert
et al., 1998). In humans, most of these oocytes degenerate before puberty, leaving about
400,000 out of an original 6 million (Wolpert et al., 1998).
Following entry into prophase I arrest, the primary oocytes begin to grow. During this
growth period, the oocytes undergo 300-fold increase in volume, accumulate a large
amount of proteins, mRNA, ribosomes, cortical granules and become surrounded by a
zona pellucida (Wassarman, 1988).19
At puberty, under the influence of hormones, the fully-grown primary oocytes can
resume the first meiotic division, a process known as meiotic maturation (Yanagimachi,
1994). At this stage of oocyte development, the nuclear (germinal vesicle - GV)
envelope breaks down (GVBD), the chromatin recondenses, the replicated homologs
separate and the oocyte divides asymmetrically to produce a large secondary oocyte (the
precursor of the egg) and a small first polar body (PB1) (Yanagimachi, 1994). During
oocyte maturation, meiosis proceeds directly to metaphase of the second meiotic division
(Met II) without intervening S phase and then arrests again, with chromosomes aligned
on the metaphase II spindle, until fertilization (Moore and Orr-Weaver, 1998). At
ovulation, the secondary oocyte (Met II-arrested oocyte) is released from the ovary to the
ampulla region of the oviduct (Runft et al., 2002). From this point the oocyte is fully
mature and ready for fertilization; as such it is defined as an egg.
1.2.3. Folliculogenesis: follicular growth
Each developing oocyte is contained within a follicle and is surrounded by layers of
granulosa cells. The ovarian follicle is the fundamental structure of the female
reproductive biology and the process of its maturation is referred to as folliculogenesis
(Gore-Langton and Armstrong, 1998; Yanagimachi, 1994). Folliculogenesis is a highly
regulated developmental sequence by which the female germ cell develops within the
somatic cells of the ovary and matures into a fertilizable egg (Knobil and Neil, 2006).
The growing follicles are usually classified in terms of their morphology, oocyte size and
granulosa cells number into primordial, primary, growing and pre-ovulatory follicles (or
Graafian follicles), from where oocytes are ovulated (Knobil and Neil, 2006).20
The process of follicular growth and oocyte maturation is mainly regulated by the
gonadotrophins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH),
which are both peptide hormones secreted by the anterior pituitary (Bukovsky et al.,
2005; Normann and Liteack, 1997; Yanagimachi, 1994). FSH stimulates granulosa cell
proliferation, estrogens biosynthesis and LH receptor expression (Normann and Liteack,
1997). LH, however, induces thecal androgens production, which in turn stimulates
estrogens production by the granulosa cells (Normann and Liteack, 1997). Follicular
estrogens feedback on both the hypothalamus and pituitary to trigger a sudden and
dramatic rise in the release of LH, the so-called “LH surge” (Normann and Liteack,
1997). The LH surge induces the pre-ovulatory maturation of the Graafian follicle,
which includes meiotic maturation of the oocyte accompanied by changes in the structure
of the Graafian follicle, to produce an ovulatory follicle consisting of a secondary oocyte
(Met II-arrested oocyte), surrounded by an optimum number of highly differentiated
granulosa cells and a large fluid-filled antrum (AUSTIN and Short, 1993). The antrum
divides the granulosa cells into two separate compartments: the cumulus cells that
directly surround the oocyte, whereas the outer layer consists of the mural granulosa cells
(AUSTIN and Short, 1993).
1.2.4. Ovulation
The ovulatory process in mammals is a distinct biological phenomenon that begins when
gonadotrophic hormones stimulate mature ovarian follicles and it ends when the follicles
rupture and release eggs into the oviduct (Knobil and Neil, 2006). It is currently believed21
that the ovarian follicle rupture at ovulation is caused by an acute inflammatory reaction
that involves the granulosa and theca cells, and which is induced by the ovulatory surge
in the gonadotrophins (Espey, 1980). This inflammatory response stimulates the
biosynthesis of proteases, which degrade the wall of the follicle and the extracellular
matrices within the ovarian connective tissue, resulting in rupture of the follicle and
release of the egg, which remains in the ampulla region of the oviduct until fertilization
(Espey, 1980).
1.2.5. Fertilization and egg activation
1.2.5.1. Fertilization
In mammals, the process of fertilization starts when the head of the sperm binds to the
zona pellucida, the glycoprotein envelope that surrounds the egg. Fertilization takes
place in the ampulla region of the oviduct, where the freshly ovulated metaphase II-
arrested egg is located. At this stage, the egg is encased within a zona and is surrounded
by a mass of cumulus cells, which are both physical barriers the sperm has to penetrate
before it can contact and fuse with the egg plasma membrane. To become competent to
overcome these vestments, the sperm must undergo two crucial events, known as
capacitation and acrosome reaction.
It was observed in 1951 that freshly ejaculated mammalian sperm were not competent to
fertilize eggs in vitro, unless they had spent a period of time in the female reproductive
tract (AUSTIN, 1951; Chang, 1951). The series of modifications the sperm undergoes22
while in the female uterus are referred to as capacitation (AUSTIN, 1952). During this
process the sperm acquires the following functional capabilities: to penetrate the cumulus
mass, to bind to the ZP and to undergo the acrosome reaction upon binding to the zona
(AUSTIN, 1952; Visconti et al., 1998). These are achieved through widespread changes
in the physiology and biochemistry of the sperm, including modifications of the plasma
membrane potential and composition, changes in the intracellular pH, alteration of the
metabolism and especially changes in the flagellar motility (Visconti et al., 1998).
Once capacitated, the next barrier the sperm encounters is the zona pellucida. As already
mentioned, the zona is a glycoprotein envelope which consists of three main
glycoproteins: ZP1, ZP2 and ZP3 (Bleil and Wassarman, 1980). ZP3 is a crucial protein,
as ZP3-knockout mice are not fertile and their oocytes lack zona (Liu et al., 1996; Rankin
et al., 1996). ZP3 serves as a receptor for species-specific binding of the sperm to the
zona, leading to the acrosome reaction in which the hydrolytic content of the acrosomal
vesicle is released by exocytosis (Florman and Wassarman, 1985; Wassarman, 1990;
Wassarman, 2005). The enzymes released include -N-acetylglucosaminidase and
acrosin, which facilitate the sperm penetration of the ZP through enzymatic dissociation
of its substances (Gilbert, 2006). In addition, the acrosomal reaction exposes proteins on
the sperm plasma membrane that mediate the binding and fusion of sperm and egg
membranes; a key player is the transmembrane protein Izumo (Inoue et al., 2005).
Accordingly, it was demonstrated that Izumo-knockout male mice are sterile, and an
antibody against human Izumo blocked the binding and fusion of human sperm with
zona-free hamster eggs (Inoue et al., 2005).23
1.2.5.2. Egg activation
Following sperm-egg membrane fusion, the egg initiates a series of processes that begin
development. These series of events, called egg activation, happen in the cytoplasm of
the egg upon fertilization and occur prior to the first cleavage (Knobil and Neil, 2006;
Runft et al., 2002). The events of egg activation can be divided into early events, which
occur within seconds of the sperm-egg fusion, and late events, which happen few hours
after fertilization (Knobil and Neil, 2006; Runft et al., 2002).
The early events of egg activation are the block to polyspermy, which is necessary to
prevent entrance of multiple sperms. In mammals, fertilization of the egg by only one
sperm is ensured by the cortical granule reaction (Ducibella, 1996). Upon sperm entry,
the cortical granules, which lie just beneath the egg plasma membrane, undergo
exocytosis and release their contents into the perivitelline space (Ducibella, 1996). The
released enzymes modify the ZP sperm receptors such that they are no longer
recognizable and able to bind sperm (Ducibella, 1996). In mouse, for example, the
cortical granules contain N-acetylglucosaminidase enzymes, which are capable of
cleaving N- acetylglucosamine from ZP3 carbohydrate chains. It has been demonstrated
that when N- acetylglucosamine residues are removed, ZP3 is no longer recognisable by
sperm (Miller et al., 1993a; Miller et al., 1993b). Exocytosis also results in the hardening
of the zona, making it more resistant to protease digestion during sperm penetration
(Gilbert, 2006).24
The late events of fertilization include resumption of the second meiotic division by the
Met-II arrested egg, leading to extrusion of one half of the chromatin within the second
polar body, leaving the egg in a haploid state (Runft et al., 2002). This is followed by
decondensation of the egg and sperm chromatin, which become surrounded by their own
nuclear envelopes, forming the female and male pronuclei (PN), respectively (Runft et
al., 2002). Within the PN, the first mitotic S-phase takes place to generate two copies of
each genome (Runft et al., 2002). Once the DNA has been replicated, the two pronuclei
are brought together in a process known as syngamy (Evans and Florman, 2002). This is
followed by the breakdown of the nuclear envelopes and recondensation of both
genomes, which then orient themselves on the first mitotic spindle, just prior to
undergoing the first embryonic cleavage (Evans and Florman, 2002).
Fertilization of the mammalian egg by sperm is associated with an explosive release in
cytosolic calcium (Ca
2+), which spreads through the egg in waves (Stricker, 1999). These
Ca
2+ oscillations are crucial for stimulating cortical granule exocytosis and activating the
egg to complete meiosis (Stricker, 1999). The cell cycle of the ovulated egg is
maintained transiently in the metaphase of the second meiotic division by the high
activity of the Maturation-Promoting Factor (MPF) (Jones, 2004; Madgwick and Jones,
2007; Mattioli et al., 1991). Loss of MPF is essential for the fertilized egg to resume its
meiotic division and to begin development. This is achieved through the Ca
2+ signals,
which are transduced by calmodulin (CaM), which in turn associates with and activates
calmodulin-dependent protein kinase II (CaMKII) (Lorca et al., 1991; Lorca et al., 1993).
Activation of CaMKII results in the degradation of the regulatory subunit of MPF (cyclin25
B1) through the Anaphase-Promoting Complex/Cyclosome (APC/C), leading to MPF
inactivation (Lorca et al., 1991; Lorca et al., 1993). Having explained the structural and
cellular events around oocyte development and maturation, the following section will
focus on (i) the role of the two major kinases (MPF and MAPK) known to control oocyte
maturation, and (ii) how the APC/C-mediated proteolysis of the various regulatory
proteins co-ordinates cell cycle progression and chromosome segregation.26
Figure 1.1. Overview of oogenesis and folliculogenesis.
Oogenesis (left) starts with the mitotic proliferation of the primordial germ cell as it
migrates to the ovary to become oogonium. After a number of mitotic divisions, the
oogonium enters the prophase of meiosis I and differentiates into a primary oocyte. The
primary oocyte remains arrested in prophase I until the female becomes sexually mature.
At this point, under the influence of hormones, the fully-grown primary oocyte resumes
meiosis I to become a secondary oocyte, arrested at metaphase II. The egg is ovulated
and remains in the metaphase II stage until fertilization, when it gets activated and
resumes its second meiotic division. Each developing oocyte is contained within a
follicle, whose process of maturation, folliculogenesis (right), occurs in parallel to
oogenesis. The growing follicle is classified in terms of certain structural characteristics
(morphology, oocyte size and number of follicle cells) into primordial, primary, growing
and pre-ovulatory Graafian follicle, from where the secondary oocyte is ovulated
(www.tarleton.edu/ ~anatomy/oogenesis.html).
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1.3. Regulation of the meiotic cell cycle in oocytes
1.3.1. Maturation-Promoting Factor (MPF)
MPF is the universal M-phase kinase. It drives somatic cells into mitosis and eggs into
meiosis (Doree and Hunt, 2002; Jones, 2004; Masui, 2001; Pines, 1999). MPF was first
characterised by Masui and Markert in 1971 as an activity present in mature oocytes that
was able to induce nuclear maturation when injected into immature prophase I-arrested
frog oocytes (Doree and Hunt, 2002; Masui and Markert, 1971). It is a heterodimeric
protein, composed of a catalytic CDK1 (Cyclin-Dependent Kinase 1) subunit and a
regulatory cyclin B subunit (Doree and Hunt, 2002; Gautier et al., 1990; Lohka et al.,
1988; Pines and Hunter, 1989).
Cyclins were initially purified in marine invertebrate embryos by their ability to fluctuate
in a cyclical pattern along the cell division cycle (Evans et al., 1983). There are at least
three types of cyclin B (B1, B2 and B3) in mammalian cells. Cyclin B1 appears to be the
physiologically important regulator of MPF in oocytes, given that knocking out cyclin B1
in GV oocytes prevents their maturation (Ledan et al., 2001), and cyclin B1 knockout
mice are non-viable (Brandeis et al., 1998). Cyclin B2 knockout mice, however, are
viable and fertile (Brandeis et al., 1998). Whereas, cyclin B3 is absent from the ovarian
tissue (Lozano et al., 2002).
MPF is the master controller of many aspects of the cell cycle due to its ability to
phosphorylate a variety of substrates, such as: (i) histone H1, which has an important role28
in chromatin condensation during cell division, (ii) nuclear laminins, leading to nuclear
envelope breakdown and (iii) RNA polymerase II, explaining the inhibition of
transcription at the final stages of oocyte maturation and during cell division (Bradbury et
al., 1974; Cisek and Corden, 1989; Heikinheimo and Gibbons, 1998; Langan et al., 1989;
Peter et al., 1990).
In mitosis, MPF activity is required in order for cells to enter M-phase and its inactivation
is needed for mitotic exit. Meiotic division, however, is characterised by two peaks of
high MPF activity occurring during meiotic maturation and metaphase II arrest. Between
MI and II, MPF activity does not experience a mitotic like decrease, instead it undergoes
a transient decrease to about 50% of the original activity, therefore allowing completion
of the first meiotic division and a rapid reactivation of MPF that leads to direct
progression to MII (Jones, 2004; Madgwick and Jones, 2007; Mattioli et al., 1991). The
sustained high MPF activity during the metaphase II arrest is due to a cytoplasmic
activity termed cytostatic factor (CSF), which was also discovered by Masui and Markert
in 1971 (see section 1.3.6).29
Figure 1.2. Profile of MPF activity during mitosis and meiosis.
In somatic cells (top), MPF activity is required for cells to enter M-phase and its
inactivation is needed to exit mitosis. In contrast, meiosis (bottom) is characterised by
two peaks of high MPF activity occurring during meiotic maturation and metaphase II
arrest. Between MI and II, there is a transient decrease in MPF explaining the lack of
interphase during this period.30
The activity of MPF is highly regulated by mechanisms responding to cell cycle
progression, which include both CDK1 phosphorylation and cyclin B1 degradation. The
newly assembled MPF complex is usually maintained in an inactive state (termed pre-
MPF) via phosphorylation of its catalytic subunit (CDK1) at Threonine-14 and Tyrosine-
15 by the specific protein kinase, Wee1 (Gu et al., 1992; Lundgren et al., 1991;
McGowan and Russell, 1993). These phosphorylation events can be reversed by the
phosphatase cdc25, which causes an activating dephosphorylation of MPF at the same
sites (Gautier et al., 1991; Millar et al., 1991). Therefore, the balance in cdc25 and Wee1
activities governs the status of CDK1 phosphorylation and MPF activation.
In addition, the activity of MPF depends on the presence or absence of its regulatory
subunit (cyclin B1) during the cell cycle, explaining the periodic pattern of MPF activity
(Evans et al., 1983; Murray et al., 1989). Cyclin B1 is usually synthesised prior to cell
division and degraded at the metaphase-to-anaphase transition, allowing exit from M-
phase (Clute and Pines, 1999; Evans et al., 1983; Murray et al., 1989). It was shown by
Murray and Kirshner (1989) that cyclin B1 destruction was necessary for MPF
inactivation and M-phase exit, given that metaphase-arrested Xenopus egg extracts that
contain the non-degradable mutant of cyclin B1 (90-cyclin B1) block at metaphase with
high MPF activity following the addition of calcium (Murray et al., 1989). Cyclin B1
degradation at the onset of anaphase is triggered via ubiquitination by the APC/C, which
is an E3 ubiquitin ligase (see section 1.3.3) (Glotzer et al., 1991).31
1.3.2. MAPK signalling cascade during meiotic maturation
The c-Mos/MEK/MAPK/p90
rsk cascade is another regulatory system that is universally
activated during meiotic maturation of vertebrate oocytes, and which functions in parallel
to and interacts with MPF in driving meiosis (Sun et al., 1999). c-Mos is a 39 kDa germ
cell-specific Ser/Thr protein kinase, which was first identified in cells transformed by
Moloney murine leukemia virus (Papkoff et al., 1982). It is the product of the proto-
oncogene c-mos, whose mRNA is stored as maternal information in the growing oocyte
and is only translated upon exit from the prophase I arrest (Gebauer and Richter, 1997).
c-Mos functions as a MAPK kinase kinase (MAPKKK), which directly phosphorylates
the MAPK kinase, MEK1 (Gebauer and Richter, 1997). Activated MEK1, in turn,
activates MAPK through dual phosphorylation on Threonine-183 and Tyrosine-185
(Crews and Erikson, 1992). MAPK, also known as Extracellular-Regulated Kinase
(ERK), exists as two isoforms in mammalian oocytes, ERK1 and ERK2 (Boulton et al.,
1991). The best-known downstream target of MAPK in oocytes is p90
rsk, a 90 kDa
ribosome S6 kinase, which is activated by ERK via phosphorylation on Serine-369 and
Threonine-577 (Dalby et al., 1998).
Unlike MPF, whose activation is crucial for resumption of oocyte meiotic maturation in
all species studied so far, the timing and requirement for MAPK activation varies in
different organisms. In Xenopus and other lower vertebrate oocytes, several lines of
evidence suggest that MAPK activation is required for progesterone-induced MPF
activation and meiotic resumption. It was shown that microinjection of constitutively
activated thiophosphorylated MAPK or MEK into Xenopus oocytes leads to MPF32
activation and GVBD in the absence of progesterone (Haccard et al., 1995; Huang et al.,
1995). However, these events were inhibited upon microinjection of a MAPK
phosphatase or anti-MEK antibody (Gotoh and Nishida, 1995; Kosako et al., 1994).
Also, progesterone-induced GVBD is always accompanied by MAPK activation in vivo
(Posada and Cooper, 1992). It is believed that progesterone causes MAPK activation
through promoting c-Mos mRNA polyadenylation and translation, resulting in the firing
of the MAPK signalling cascade, followed by MPF activation and GVBD (Sheets et al.,
1995). Accordingly, microinjection of c-Mos triggers GVBD in a progesterone-
independent manner (Sagata et al., 1989a). Conversely, progesterone-induced MPF
activation and GVBD are prevented when the translation of c-Mos mRNA is inhibited by
microinjection of antisense oligonucleotides (Sagata et al., 1988). Taken together these
results confirm that progesterone-dependent stimulation of the c-Mos/MAPK cascade
plays an important role in initial activation of MPF and meiotic resumption in lower
vertebrate oocytes.
However, recent studies have challenged this idea, with the authors suggesting that
progesterone-induced GVBD does not require MAPK, and other MAPK-independent
pathways could trigger MPF activation. In agreement with this, it was reported that
inhibition of MAPK activity using the MEK inhibitor UO126 or by over-expression of
the MAPK phosphatase Pyst1, does not block MPF activation and GVBD upon
progesterone stimulation (Fisher et al., 1999; Smythe and Stricker, 2005). Nevertheless,
it is worth mentioning that in these cells although GVBD is not blocked, it is delayed and
meiotic maturation happens less efficiently (Fisher et al., 1999).33
In mammalian oocytes, the sequence of events differs with MAPK activation occurring
after GVBD. This indicates that the MAPK phosphorylation cascade is not required for
MPF activation and spontaneous meiotic resumption in mammals (Kalab et al., 1996;
Verlhac et al., 1993). Indeed, inhibition of MAPK activation by the MEK inhibitor
UO126 does not affect GVBD in mouse oocytes (Tong et al., 2003). Also, analysis of
oocytes from c-mos knockout mouse has shown that GVBD occurs normally, while no
activation of MAPK is detected in these cells (Hashimoto et al., 1994; Verlhac et al.,
1996).
Although these studies show that MAPK activity is not necessary for GVBD in frog and
mammalian oocytes, it is very important for the regulation of subsequent meiotic events.
In addition to its vital role in keeping the CSF arrest (Colledge et al., 1994; Hashimoto et
al., 1994), which I will discuss more later (see section 1.3.6), several lines of evidence
suggest that the MAPK cascade is also required for the maintenance of microtubules and
chromatin in the metaphase state during the MI to MII transition, when the levels of MPF
activity are low. It was reported that addition of MAPK to Xenopus interphase extracts
induces the shortening of the elongated microtubules (Gotoh et al., 1991), and
microinjection of anti-Mos antibody into mouse oocytes prevents the assembly of a
meiotic spindle (Zhao et al., 1991). Moreover, c-mos
-/- mouse oocytes present abnormal
spindles with interphase-like elongated microtubules, and fail to keep the chromosomes
condensed at the MI to MII transition (Hashimoto et al., 1994; Verlhac et al., 1996).34
Figure 1.3. MAPK activity during meiosis in mammalian oocytes.
In spontaneous meiotic maturation of mammalian oocytes, MAPK activation occurs at
approximately 2 hours after GVBD and is inactivated at 6 hours following egg activation,
just prior to pronuclei formation. Between MI and II, unlike MPF whose activity drops
slightly, MAPK activity remains high and this is important for the maintenance of
microtubules and chromatin in the metaphase state.35
Besides MAPK involvement in the organization and maintenance of the metaphase
spindle, it is also important for the migration of the meiotic spindle to the cortex, leading
to asymmetric divisions in oocytes and extrusion of small polar bodies. Accordingly,
inhibition of MAPK leads to failure of spindle migration to the cortex, resulting in
extrusion of abnormally large polar bodies (Choi et al., 1996; Hashimoto et al., 1994).
Since, spindle migration to the cortex depends on actin microfilaments and not
microtubules (Al et al., 2008; Azoury et al., 2008; Sun and Schatten, 2006), then the
MAPK cascade might also control the actin-microfilament network.
Finally, there is also evidence associating MAPK with the spindle assembly checkpoint,
suggesting that in the absence of MAPK activity, Xenopus and mouse oocytes fail to
activate the SAC and to arrest the cell cycle at metaphase following microtubule
depolymerisation (Takenaka et al., 1997; Verlhac et al., 1996). It has also been reported
that MAPK is important for re-activating MPF after anaphase I (Gross et al., 2000; Taieb
et al., 2001), and its inactivation seems to be crucial for pronuclei formation following
fertilization (Moos et al., 1996).
1.3.3. The Anaphase Promoting Complex/Cyclosome (APC/C)
Cell proliferation in all eukaryotes depends on the E3 ubiquitin ligase activity of the
anaphase promoting complex/cyclosome (APC/C), which is primarily required for
mitotic/meiotic progression and exit (Peters, 2006). The APC/C is a 1.5 MDa protein
complex that performs its various functions by assembling chains of at least four
ubiquitin molecules on lysine residues in key regulatory proteins, such as cyclin B1 and36
securin, thus targeting them for degradation by the 26S proteasome (Peters, 2006). The
destruction of securin is important for activation of the protease separase, subsequently
allowing segregation of chromosomes (Madgwick et al., 2004; Terret et al., 2003). The
degradation of cyclin B1 is crucial for anaphase onset through MPF inactivation (Lorca et
al., 1993).
The vertebrate APC/C is composed of at least a dozen different subunits, most of which
were highly conserved throughout evolution and whose modification by genetic
manipulation leads to early lethality in every species examined so far (Baker et al., 2007;
Yoon et al., 2002; Zachariae et al., 1996; Zachariae et al., 1998b). APC/C-mediated
ubiquitination of its substrates requires the help of 3 main cofactors, in addition to its E3
ubiquitin ligase activity it needs a ubiquitin-activating enzyme (E1), a ubiquitin-
conjugating enzyme (E2), and a co-activator protein (Peters, 2006).
The transfer of ubiquitin to a target substrate is performed in three steps. First, ubiquitin,
which is a highly conserved 76-amino acids protein, is activated by E1 in a reaction that
requires ATP in order to create a high-thioester bond between the cysteine residue at the
enzyme’s active site and the glycine residue of ubiquitin (Ciechanover et al., 1981; Haas
et al., 1982; Hershko et al., 1981). The activated ubiquitin is then transferred to the
active site of the ubiquitin-conjugating enzyme (E2) (Hershko et al., 1983). Finally,
ubiquitin is transmitted to the side chain of a lysine residue on the target protein via an E3
ubiquitin ligase, such as the APC/C (Hershko and Ciechanover, 1998).37
Figure 1.4. Separase activation and MPF inactivation are required for M-phase exit.
At the metaphase-to-anaphase transition, APC/C targets cyclin B1 and securin for
proteolysis. Cyclin B1 destruction is crucial for MPF inactivation and anaphase onset.
However, Securin degradation is required for separase activation, and so sister chromatid
separation.38
Figure 1.5. The ubiquitin pathway.
The transfer of ubiquitin to a target substrate is done in three steps. First, ubiquitin is
activated by the ubiquitin-activating enzyme (E1) in a reaction that requires ATP. The
activated ubiquitin is then transferred to the active site of the ubiquitin-conjugating
enzyme (E2). Finally, an E3 ubiquitin ligase, such as the APC/C, transmits ubiquitin to
the target protein, therefore triggering its recognition and destruction by the proteasome.39
In addition to the core subunits, several co-activator proteins (non-core subunits)
transiently associate with and activate the APC/C during specific periods of the cell
cycle, and the best studied of these are Cdc20 (Cell division cycle 20) and Cdh1 (Cdc20
homologue 1) (Visintin et al., 1997). Cdc20 (also called fizzy in Drosophila) was initially
identified in a mutant form of budding yeast that had similar arrest phenotypes as cells
mutant for the APC/C subunits, and in Drosophila where the fizzy mutants failed to
degrade the mitotic cyclins (Dawson et al., 1993; Hartwell et al., 1970; Hartwell et al.,
1973; Sigrist et al., 1995). Similarly, Cdh1 (also known as fizzy-related in Drosophila)
was found to be required for the activity of the APC/C during late mitosis and G1 in
budding yeast, and for maintaining the low levels of cyclins during G1 in Drosophila
(Schwab et al., 1997; Schwab et al., 2001; Sigrist and Lehner, 1997; Visintin et al.,
1997).
These two co-activators are characterised by the presence of specific APC/C binding
sequence elements, known as the IR-tails (Isoleucine-Arginine dipeptide motifs) (Visintin
et al., 1997). They also contain WD40 domains (Tryptophan-Aspartate repeats) in their
C terminus, which fold into seven-bladed propeller like structures that are believed to
recognise the APC/C substrates by interacting with specific recognition elements, known
as D-box, KEN-box and CRY-box (Glotzer et al., 1991; Pfleger and Kirschner, 2000;
Reis et al., 2006b; Visintin et al., 1997). D-box (Destruction-box) recognition elements
contain the consenus amino acid sequence RXXLXXXN (Glotzer et al., 1991), whereas
the KEN-box is composed of a KEN amino acid sequence (Pfleger and Kirschner, 2000).
CRY-box, however, consists of the consenus sequence CRYXPS (Reis et al., 2006b).40
Different APC/C complexes associated with different co-activators tend to have different
substrate specificities. APC/C
Cdc20 recognises proteins that contain a D-box such as
securin and cyclin B1, whereas APC/C
Cdh1 is able to recognise proteins with either a D-,
KEN- or CRY-box such as securin, cyclin B1 and Cdc20 (Hagting et al., 2002; Visintin
et al., 1997).
1.3.3.1. Regulation of the APC/C during the mitotic cell cycle
In mitosis the APC/C is activated in prometaphase and remains active until late G1 but its
activity is tightly controlled by various mechanisms to ensure proper timing of
degradation of each of its substrates. Initial activation of the APC/C involves
phosphorylation of its various subunits by the mitotic kinases Plk1 (Polo-like kinase 1)
and CDK1, and the recruitment of Cdc20 (Hershko et al., 1994; Kraft et al., 2003).
However, premature APC/C
Cdc20 mediated ubiquitination of its substrates is prevented
through the association of Cdc20 with the early mitotic inhibitor (Emi1) (Miller et al.,
2006; Reimann et al., 2001). Also, via Cdc20 phosphorylation by CDK1 and MAPK,
resulting in Cdc20 recognition and inhibition by the components of the spindle assembly
checkpoint (SAC) (Chung and Chen, 2003).
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Figure 1.6. The APC/C recognition elements in cyclin B1, securin and cdc20
APC/C
Cdc20 and APC/C
Cdh1 recognise their substrates by interacting with different
recognition elements, most commonly D-box, KEN-box and CRY-box. D-box
containing proteins are targeted for destruction by either APC/C
Cdc20 or APC/C
Cdh1,
whereas, substrates with either KEN- or CRY-box are recognised by APC/C
Cdh1. The
residues numbers indicate the location of the destruction motifs within each APC/C
substrate in mouse.42
In prophase, Emi1 becomes phosphorylated by Plk1 and is targeted for destruction
through ubiquitination by SCF (Skp1/Cullin/F-box protein complex), which is another E3
ubiquitin ligase that is important in controlling the G1/S and G2/M transitions, whereas
the APC/C is required for mitotic progression and exit (Hansen et al., 2004; Moshe et al.,
2004). Upon Emi1 destruction, APC/C
Cdc20 becomes active against the early mitotic
substrates, such as Cyclin A and Nek2A (den Elzen and Pines, 2001; Geley et al., 2001;
Hames et al., 2001), but it remains inhibited by the components of the spindle assembly
checkpoint from prematurely targeting securin and cyclin B1 for degradation (Fang et al.,
1998; Rieder and Maiato, 2004; Yu, 2002).
The spindle assembly checkpoint is a surveillance mechanism, which ensures the fidelity
of chromosomes segregation through monitoring the state of their attachment to the
spindle microtubules (Kops et al., 2005; Rieder et al., 1994). It consists of a network of
proteins, and the key players include Bub1, Bub3, Mad1, Mad2, Mad3/BubR1, Mps1 and
Aurora B. These proteins localize to the tensionless-unattached kinetochores, the
structures that mediate the interactions between centromeric DNA and spindle
microtubules, hence activating the SAC signalling pathway (Rieder et al., 1995). This in
turn prevents anaphase onset and progression through the cell cycle via sequestration and
inhibition of the APC/C co-activator, Cdc20 (Fang et al., 1998; Rieder et al., 1994;
Rieder and Maiato, 2004; Yu, 2002). Therefore, the APC/Cis incapable of ubiquitinating
securin and cyclin B1, whose destruction is crucial for M-phase exit.43
At anaphase onset, when all chromosomes achieve proper bipolar attachment to the
spindle, the SAC is turned off and Cdc20 is released to trigger APC/C activation (Mao et
al., 2003), which in turn targets securin and cyclin B1 for destruction by the proteasome,
thereby allowing resumption of the cell cycle, sister chromatids separation and exit from
mitosis.
Meanwhile, although Cdh1 levels are high, it is unable to associate with the APC/C due
to its phosphorylation by CDK1 (Jaspersen et al., 1999). Following MPF inactivation via
APC/C
Cdc20-induced degradation of cyclin B1, Cdh1 is dephosphorylated by the
phosphatase cdc14, thus allowing its binding and activation of the APC/C (Jaspersen et
al., 1999). APC/C
Cdh1 induces the destruction of several regulatory proteins, known as
the late mitotic proteins, such as Plk1 and the Aurora kinases, whose degradation allows
exit from mitosis and entry into G1 ( Castro et al., 2002; Lindon and Pines, 2004;
Littlepage and Ruderman, 2002; Stewart and Fang, 2005). Accordingly, it was recently
reported by Floyd et al (2008) that APC/C
Cdh1 is required for the assembly of a spindle
midzone at anaphase, and for normal timing of spindle elongation and cytokinesis
through targeting the Aurora kinsases for destruction (Floyd et al., 2008).
The activity of APC/C
Cdh1 continues through G1, where it targets Cdc20 and the mitotic
cyclins for destruction, therefore preventing their premature accumulation, and so
premature entry into S-phase (Prinz et al., 1998). Indeed, a study by Garcia-Higuera and
colleagues (2008) demonstated that mouse MEFs lacking Cdh1 exhibit a slow exit from
mitosis as well as a fast progression from G1 to S-phase (Garcia-Higuera et al., 2008). It44
was also found by the same group that inactivation of mouse Cdh1 results in embryonic
lethality due to placental insufeciency, which is believed to be arising from a failure of
placental trophoblasts to re-duplicate, a phenotype that is consistent with the role of Cdh1
in controlling DNA replication (Garcia-Higuera et al., 2008).
In late G1 and during S phase, Cdh1 also becomes subject to ubiquitin-mediated
degradation by the APC/C
Cdh1 and SCF, respectively (Benmaamar and Pagano, 2005;
Listovsky et al., 2004). It was demonstrated by Listovsky et al that addition of Cdh1 to
Xenopus interphase extracts, which have an inactive APC/C, activates it to mediate its
own destruction in a D-box dependent manner (Listovsky et al., 2004). Additionally, it
was shown by Benaamar and Pagano that inhibition of SCF during S-phase leads to Cdh1
accumulation (Benmaamar and Pagano, 2005).
However, recent work on the nuclear transport factors Rae1 and Nup98 has challenged
this view of APC/C
Cdh1 being only active in late mitosis and during G1 (Jeganathan et al.,
2005). It was found that mice with combined Rae1 and Nup98 haploinsufficiency exhibit
premature separation of sister chromatids and severe aneuploidies, due to unscheduled
APC/C
Cdh1-mediated destruction of securin during prometaphase (Jeganathan et al.,
2005). This study demonstrates that securin associates with the APC/C
Cdh1 during early
mitosis, but its destruction is delayed by the nuclear transport factors Rae1 and Nup98
until the metaphase-to-anaphase transition (Jeganathan et al., 2005).45
1.3.3.2. Regulation of the APC/C during the meiotic cell cycle
In meiosis, however, even less is known about the regulation of both APC/C
Cdc20 and
APC/C
Cdh1 in higher organisms and most of our understanding comes from yeast,
Drosophila and Xenopus. Cdc20, but not Cdh1, is believed to be the mediator of meiotic
exit in eggs of species described thus far (Chang et al., 2004; Lorca et al., 1998). In
Xenopus eggs, it was reported that Cdh1 is absent and is not expressed till the mid-
blastula transition stage, and that Cdc20 inhibition results in prevention of exit from
meiosis II upon egg activation (Chang et al., 2004; Lorca et al., 1998). Also in
Drosophila, it was demonstrated that Cdh1 is absent during the early syncytial stages of
embryogenesis, and it becomes functional only following cellularisation, where it targets
cytoplasmic cyclin B1 for destruction (Chang et al., 2004; Raff et al., 2002; Sigrist and
Lehner, 1997). Finally, Cdh1 knockdown using RNAi in C.elegans embryos does not
affect their development (Fay et al., 2002), whereas depletion of Cdc20 leads to
metaphase I arrest (Kitagawa et al., 2002).
In mice, on the other hand, Cdh1 is present during meiosis (Chang et al., 2004).
However, unlike mitosis, the activity of APC/C
Cdh1 precedes that of APC/C
Cdc20. Cdh1
appears to play an important role during prophase I and prometaphase I (Marangos et al.,
2007; Reis et al., 2006a; Reis et al., 2007). It was shown that APC/C
Cdh1 is required for
maintaining the prophase I arrest by suppressing the rise in cyclin B1 levels (Marangos et
al., 2007; Reis et al., 2006a). During this period, however, the activity of APC/C
Cdh1 is
restrained by Emi1, hence preventing complete depletion of cyclin B1 such that enough
pre-MPF is available in readiness for meiotic resumption (Marangos et al., 2007). This46
was reported by Marangos et al, who found that depletion of Emi1 through injection of
morpholino antisense oligonucleotides (morpholinos) in GV mouse oocytes delays entry
into meiosis I through inhibition of cyclin B1 accumulation (Marangos et al., 2007).
At GVBD, Emi1 is targeted for destruction through ubiquitination by SCF, resulting in an
increase in APC/C
Cdh1 activity (Marangos et al., 2007). Following germinal vesicle
breakdown and during prometaphase I, APC/C
Cdh1 targets Cdc20 for degradation in
preference to cyclin B1 and securin, thereby delaying the onset of APC/C
Cdc20 activity
and anaphase I (Reis et al., 2007). It was reported by Reis et al that injection of mouse
oocytes with Cdh1 morpholinos accelerates progression through meiosis I, resulting in
premature anaphase onset and chromosomes segregation, but non-disjunction of
homologs (Reis et al., 2007). Therefore, this delay in the onset of APC/C
Cdc20 activity
seems to be crucial in allowing more time for homologs to congress properly on the
metaphase I plate (Reis et al., 2007).
The rising levels of MPF activity during meiosis I eventually lead to inactivation of
APC/C
Cdh1 (Jaspersen et al., 1999), which then allows the accumulation of Cdc20.
APC/C
Cdc20 activity, however, remains on hold by the components of the SAC until
anaphase I onset, when it induces the degradation of securin and cyclin B1, thus
promoting homolog segregation and exit from meiosis I (Brunet et al., 2003; Homer et
al., 2005a; Homer et al., 2005b; Wassmann et al., 2003; Zhang et al., 2004).47
Between MI and II, MPF activity does not experience a mitotic like decrease; instead it
undergoes a transient decline to about 50% of its original activity, which is required for
the MI-to-MII transition and the return to metaphase II (Hashimoto and Kishimoto, 1986;
Hashimoto and Kishimoto, 1988; Madgwick et al., 2006; Madgwick and Jones, 2007;
Mattioli et al., 1991). This is achieved by the Emi1 homologue, Emi2, which limits
APC/C
Cdc20 activity, thereby allowing cyclin B1 stability and a return of MPF activity
(Madgwick et al., 2006; Ohe et al., 2007; Schmidt et al., 2004). In Xenopus and mouse
oocytes, it was found that depletion of Emi2 reduces cyclin B1 re-accumulation after
meiosis I, prevents entry into meiosis II and induces DNA replication (Madgwick et al.,
2006; Ohe et al., 2007).
Following entry into the second meiotic division and metaphase II arrest, APC/C
Cdc20 is
kept inactive by the components of SAC and CSF (Madgwick and Jones, 2007; Tunquist
and Maller, 2003). At fertilization, the Ca
2+ oscillations that are transduced by
calmodulin, activate calmodulin-dependent protein kinase II and the phosphatase
calcineurin, leading to degradation of the components of CSF and activation of
APC/C
Cdc20 (Jones, 2005; Runft et al., 2002). This induces securin and cyclin B1
destruction, which in turn results in anaphase II onset and sister chromatid separation.
Following PB2 extrusion, APC/C
Cdh1 activity increases again and it remains high until
pronuclei formation in the 1-cell embryo (Chang et al., 2004). Having provided an
overview of the key players in the control of oocyte maturation, I will now focus on the
molecular mechanisms underlying the cell cycle transitions in meiosis in mammalian
oocytes.48
Figure 1.7. Profile of APC/C
Cdc20 and APC/C
Cdh1 activities during mitosis and
meiosis. (A) In mitosis, at the metaphase-to-anaphase transition APC/C
Cdc20 becomes
fully active, targeting securin and cyclin B1 for degradation, thus allowing chromosomes
separation. This is followed by APC/C
Cdh1 activation at telophase, which continues until
late G1, where it targets late mitotic proteins including Cdc20. (B) In meiosis, however,
APC/C
Cdh1 activity is present during prophase I arrest and prometaphase I. APC/C
Cdh1 is
first required for maintaining the GV arrest by suppressing cyclin B1 levels. However,
during this period, APC/C
Cdh1 is restrained by Emi1 to prevent complete depletion of
cyclin B1 such that enough pre-MPF is available for meiotic resumption. After GVBD
and during prometaphase I, APC/C
Cdh1 is active again, and targets Cdc20 for degradation
in preference to cyclin B1, therefore delaying the onset of APC/C
Cdc20 activity and
anaphase I. The rising levels of MPF activity eventually lead to inactivation of
APC/C
Cdh1 and Cdc20 accumulation. APC/C
Cdc20 activity, however, remains on hold by
SAC until anaphase I onset, when it induces securin and cyclin B1 destruction, thus
allowing homlog segregation. Following entry into meiosis II, APC/C
Cdc20 is kept
inactive during metaphase II arrest by the components of SAC and CSF. At fertilization,
APC/C
Cdc20 is active again, therefore promoting sister chromatids separation. This is
followed by APC/C
Cdh1 activation after PB2 extrusion, which continues until pronuclei
formation.49
1.4. The molecular mechanisms governing cell cycle transitions in
meiosis in mammalian oocytes
1.4.1. Prophase I arrest in oocytes
Following entry into meiosis, oocytes become arrested at prophase of the first meiotic
division for a period lasting from few months (mice) to many years (humans), until
puberty when the female becomes sexually mature. It is well established that this meiotic
arrest is maintained by the high levels of intra-oocyte cyclic adenosine 3’, 5’-
monophosphate (cAMP) (Conti et al., 2002). It is also known that mammalian oocytes,
in contrast to frog oocytes, when released from their follicles undergo spontaneous
meiotic maturation (Pincus and Enzmann, 1935). This, however, can be prevented by
addition of agents that raise intracellular cAMP, such as membrane-permeable cAMP
analogs, cAMP phosphodiesterase (PDE) inhibitors or adenylyl cyclase (AC) activators,
to the culture media (Cho et al., 1974; Conti et al., 2002; Dekel and Beers, 1978;
Olsiewski and Beers, 1983).
The high cAMP level that is required for the maintenance of the prophase arrest is
generated by the oocyte itself. This is achieved by way of a constitutively active G
protein-coupled receptor (GPR3) in the oocyte plasma membrane that stimulates a
heterotrimeric G protein of the Gs family, which in turn activates adenylyl cyclase to
cause an elevation of cAMP. Consistent with this idea, it was reported that oocytes from
GPR3 knockout mice fail to arrest at prophase I and undergo spontaneous meiotic
maturation within intact follicles and in the absence of LH stimulation (Mehlmann et al.,50
2004). Also, it was found that microinjection of a Gs blocking antibody into follicle-
enclosed oocytes causes exit from prophase I arrest (Mehlmann et al., 2002). Moreover,
AC3 deficient mice oocytes undergo GVBD within their follicles (Horner et al., 2003).
Taken together, these findings demonstrate the essential role of the GPR3/Gs/AC
pathway in the maintenance of the meiotic arrest.
In mammals, the somatic cells that surround the oocyte within the ovarian follicle are
also required for maintaining the GV arrest, as removal of oocytes from their follicles
causes spontaneous meiotic resumption due to the decrease in intra-oocyte cAMP levels
(Pincus and Enzmann, 1935; Vivarelli et al., 1983). This suggests that the surrounding
somatic cells also contribute to the maintenance of the elevated cAMP levels. Although
the exact mechanism is still under investigation, it is believed that this is achieved
through an inhibitory signal that diffuses from the follicular cells to the oocyte via gap
junctions (Bornslaeger and Schultz, 1985; Larsen et al., 1986; Racowsky et al., 1989;
Webb et al., 2002). Indeed, application of gap junction inhibitors to rat follicles causes a
decrease in intra-oocyte cAMP and meiotic resumption (Sela-Abramovich et al., 2006).
One possibility is that the signal that diffuses from the somatic cells into the oocyte is
cAMP itself. However, it was found that the amount of cAMP generated by the follicular
cells is insufficient to maintain the prophase arrest upon inhibition of cAMP generation in
the oocyte (Mehlmann et al., 2002; Mehlmann, 2005b). Recently, it was reported that the
inhibitory signal might well be cyclic guanosine 3’, 5’-monophosphate (cGMP), which is
produced by the follicular somatic cells and diffuses into the oocyte via gap junctions.
Once inside the oocyte, it is believed that cGMP maintains the prophase arrest through51
inhibiting cAMP hydrolysis by the phosphodiesterase type 3A (PDE3A) (Norris et al.,
2009; Tornell et al., 1990). Consistent with this hypothesis, intra-oocyte cGMP decreases
after removal of the oocyte from the follicle, and meiotic resumption is delayed upon
injection of cGMP into the oocyte (Tornell et al., 1990). Also, decreasing cGMP in
follicle-enclosed oocytes via injection of the cGMP-specific phosphodiesterase PDE9A,
causes PDE3A-dependant decrease in cAMP levels and meiotic resumption (Norris et al.,
2009).
The molecular mechanism underlying cAMP-mediated arrest in mammalian oocytes is
not fully understood. However, it is generally accepted that the main downstream target
of cAMP is Protein Kinase A (PKA), leading to its activation. Active PKA plays a
crucial role in the maintenance of the GV arrest, given that injection of PKA inhibitors
causes resumption of meiosis, and its over-activation blocks meiotic maturation
(Bornslaeger et al., 1986; Duckworth et al., 2002; Maller and Krebs, 1977). PKA-
mediated Prophase I arrest is believed to be achieved through prevention of pre-MPF
activation, via direct regulation of the kinase Wee1 and the phosphatase cdc25
(Duckworth et al., 2002; Han et al., 2005; Pirino et al., 2009). As mentioned before, the
newly assembled MPF is maintained in an inactive pre-MPF form through
phosphorylation of CDK1 at Thr-14 and Tyr-15 by Wee1 (Fattaey and Booher, 1997;
Mueller et al., 1995). These phosphorylation events can be reversed by cdc25
phosphatase, resulting in MPF activation and promotion of cell cycle progression
(Lincoln et al., 2002). It has recently been reported that PKA directly phosphorylates
both Wee1 and cdc25. In mouse oocytes, it was demonstrated that PKA-mediated52
phosphorylation of Wee1 enhances its kinase activity, and therefore ability to prevent
meiotic resumption through inhibition of MPF (Han et al., 2005). Phosphorylation of
cdc25 by PKA, however, leads to its inactivation. In frog oocytes, it was reported that
PKA-mediated phosphorylation of cdc25 results in its binding to 14-3-3 and
sequestration away from pre-MPF, hence inhibiting pre-MPF activation by cdc25 and
preventing exit from the prophase arrest (Duckworth et al., 2002).
1.4.2. Resumption of meiosis I
Mammalian oocytes remain arrested in prophase I until the preovulatory surge of LH
from the pituitary gland (Mehlmann, 2005a). LH stimulates meiotic resumption
indirectly, through acting on the mural granulosa cells in the outer region of the follicle
rather than the oocyte itself, since the LH receptors are only found on the mural granulosa
cells (Peng et al., 1991). The LH signal is then conveyed inward from the mural
granulosa cells, through the cumulus cells to the oocyte, where it causes a decrease in
cAMP levels. This consequently results in meiotic resumption through the inactivation
of PKA, and the subsequent activation of pre-MPF that is brought about via the inhibition
of CDK1 phosphorylation by Wee1 and the promotion of its dephosphorylation by cdc25.
Although, it is not completely understood how the action of LH on the somatic cells
decreases oocyte cAMP, two hypotheses (pathways) have been put forth. In the first
pathway, it is believed that LH causes the synthesis of EGF-like peptides by the follicular
cells, resulting in activation of the EGF receptors and the MAPK cascade in the somatic
cells (Norris et al., 2008). The active MAPK, in turn, triggers the closure of gap53
junctions throughout the somatic compartment via phosphorylation of connexin 43
(CX43), a major component of the somatic cell junctions (Beyer et al., 1989; Norris et al.,
2008; Okuma et al., 1996). The gap junction’s closure reduces the flux of cGMP from
the follicular cells to the oocyte, leading to a decrease in intra-oocyte cGMP levels
(Norris et al., 2009; Norris et al., 2008). This loss of cGMP allows PDE3A to consume
cAMP leading to meiotic resumption (Norris et al., 2009; Norris et al., 2008). Although
this pathway is sufficient to cause exit from the prophase arrest, another pathway that
does not involve the MAPK-dependent closure of gap junctions must exist, given that
inhibition of MAPK activation using UO126 prevents gap junction closure but not
meiotic resumption in response to LH (Norris et al., 2009). This suggests that the second
pathway can cause a decrease in oocyte cAMP levels and meiotic progression without
closure of gap junctions. Indeed, a recent work by Norris et al have demonstrated that
LH also decreases the level of cGMP in the somatic cells of the follicle, leading to a
decline in oocyte cGMP (Norris et al., 2009). This consequently results in PDE3A
activation, a decrease in intra-oocyte cAMP levels and meiotic resumption (Norris et al.,
2009).
Exit from prophase I arrest is also associated with a rapid increase in cyclin B1 synthesis,
although most species contain enough pre-MPF to initiate GVBD. The timing and
requirement for cyclin B1 synthesis varies between different species. In mouse, for
example, cyclin B1 translation is only enhanced following GVBD (Fulka et al., 1986;
Polanski et al., 1998). In Xenopus oocytes, however, cyclin B1 synthesis is a
prerequisite to GVBD. This was demonstrated by Sagata and co-workers, who showed54
that progesterone-dependent MPF activation and GVBD in Xenopus oocytes were
suppressed upon the expression of a dominant negative mutant of CDK1, which was
expected to bind cyclin B1 and to form inactive MPF complexes (Furuno et al., 1994).
This result indicates that de novo synthesis of cyclin B1 is required for MPF activation
and resumption of meiosis in Xenopus oocytes. This species-specific requirement for
cyclin B1 synthesis might be due to the difference in the ratios of CDK1/cyclin B1
between species. The concentration of cyclin B1 in GV-arrested mouse ooctyes is about
sevenfold higher than that of CDK1 (Kanatsu-Shinohara et al., 2000). In Xenopus
oocytes, however, cyclin B1 levels are fiftyfold lower than those of CDK1 (Kobayashi et
al., 1991). This suggests that in mouse oocytes most of CDK1 molecules are in
complexes with cyclin B1, and therefore protein synthesis is dispensable for meiotic
resumption. In Xenopus oocytes, on the other hand, cyclin B1 synthesis is necessary for
CDK1 activation and the onset of maturation, given that most of CDK1 is free.
In addition to cyclin B1 synthesis, meiotic resumption is coupled with the translation of a
pool of maternal mRNAs, which are stored in the GV oocyte with short poly (A) tails,
generally 30-50 nucleotides, and therefore are translationally repressed (masked)
(Richter, 1999). Upon release from the prophase arrest, those dormant mRNAs undergo
polyadenylation, the process by which the poly (A) tails are extended to 80-250 residues,
resulting in their unmasking and promotion of translation (Richter, 1999). One such
mRNA that undergoes this type of modification is the one encoding c-MOS kinase. It is
believed that PKA inactivation stimulates the polyadenylation of c-Mos mRNA leading
to its translation, and activation of the MAPK phosphorylation cascade in the oocyte55
(Dekel, 2005; Gebauer et al., 1994). As previously mentioned, although the c-
Mos/MEK/MAPK/p90
rskpathway is not necessary for exit from prophase I arrest, several
lines of evidence suggest that there is a link between MAPK cascade and pre-MPF
activation. It has been reported that MAPK activation slows the rate of CDK1
inactivation in Xenopus oocytes (Abrieu et al., 1997). More importantly, it was found
that p90
rsk specifically associates with and phosphorylates Wee1 in vitro, decreasing its
ability to phosphorylate CDK1 (Palmer et al., 1998). These results suggest that, at least in
frog oocytes, the MAPK pathway is able to promote MPF activation through the
downregulation of CDK1 inhibitory phosphorylation by Wee1.
An additional potential contribution of the c-Mos/ MAPK cascade to MPF activation at
GVBD is through promoting the synthesis of its regulatory subunit, cyclin B1. It has
been demonstrated that there is a strong temporal correlation between MAPK activity and
cyclin B1 translation. It was found that de novo synthesis of cyclin B1 in c-Mos depleted
mouse oocytes is suppressed (Okeefe et al., 1991). Also, cyclin B1 mRNA
polyadenylation does not occur in response of progesterone if MAPK activity is inhibited
in frog oocytes (deMoor and Richter, 1997). All these results suggest that MAPK
activation is also required for the translation of cyclin B1 mRNA through promoting its
polyadenylation.
Following GVBD, the chromatin recondenses and the replicated chromosomes align
themselves on the metaphase plate of the first meiotic spindle, such that each pair of
homologous chromosomes is attached to opposite poles of the spindle. Therefore, at the56
onset of anaphase I, the homologs separate and half are lost from the oocyte during the
asymmetric cell division, which gives rise to a large secondary oocyte and a small PB1.
Without intervening S phase, the haploid oocyte proceeds directly to metaphase of the
second meiotic division and then arrests again, with chromosomes aligned on the
metaphase II spindle, until fertilization or parthenogenetic activation of the egg.
1.4.3. Metaphase II arrest in oocytes
To prevent parthenogenesis or completion of meiosis before fertilization, vertebrate eggs
are arrested at metaphase of meiosis II with high MPF by a cytoplasmic activity termed
cytostatic factor (CSF), which inhibits the APC/C from mediating cyclin B1 destruction
(Harper et al., 2002; Madgwick and Jones, 2007; Masui and Markert, 1971; Peters,
2002). Unlike MPF, CSF identity has never been completely resolved, despite their
simultaneous identification (Masui and Markert, 1971). CSF was first characterised by
Masui and Markert in 1971 as an activity present in mature Met II-arrested eggs that was
able to induce metaphase arrest when injected into dividing embryonic cells (Masui and
Markert, 1971). It was found that CSF activity accumulates during oocyte maturation, is
necessary and sufficient for metaphase arrest, and is inactivated during fertilization in a
Ca
2+-dependent manner (Masui and Markert, 1971).
In frog and mammalian eggs, there is much evidence to suggest that the c-
Mos/MEK/MAPK/p90
rsk pathway is an important component of CSF. It was found that
microinjection of c-Mos mRNA, active MAPK or active p90
rsk in Xenopus embryos
induces a metaphase arrest (Gross et al., 1999; Haccard et al., 1995; Sagata et al., 1989b).57
Conversely, immunodepletion of c-Mos from Met II-arrested egg extracts causes a loss of
the cleavage-arresting activity in the injected embryos (Sagata et al., 1989b). Also, the
oocytes of c-mos knockout mouse, following “normal” progression through MI, they fail
to arrest at MII and instead they spontaneously activate and extrude a second polar body
(Colledge et al., 1994). Furthermore, treatment of Met II-arrested mouse eggs with the
MEK inhibitor, UO126, induces their parthenogenetic activation (Tatemoto and Muto,
2001; Tong et al., 2003). All these results suggest that the MAPK pathway is necessary
for the maintenance of the CSF arrest. However, it is unlikely to constitute the full CSF
activity and the most compelling evidence is that although the MAPK cascade has
already been activated before MI, it does not cause MI arrest (Fan et al., 2002). Also,
MPF inactivation at fertilization precedes MAPK inactivation, showing that MAPK
activity might be required for the establishment of the CSF arrest but its inactivation is
not necessary for the release from the MII arrest (Fan et al., 2002).
Recently, the egg specific protein Emi2 has been identified as the molecule directly
responsible for APC/C inhibition during CSF arrest in both Xenopus and mice (Schmidt
et al., 2005; Shoji et al., 2006). It has been proven that Emi2 satisfies the three historical
criteria for the molecular identification of CSF: (i) it accumulates during egg maturation
(Schmidt et al., 2005), (ii) it is necessary and sufficient for metaphase arrest, since Emi2
deficient oocytes fail to enter MII after completion of MI (Madgwick et al., 2006; Ohe et
al., 2007) and knocking down its activity in Met II-arrested eggs results in their
parthenogenetic activation (Shoji et al., 2006), and finally (iii) it is rapidly degraded in
response to Ca
2+ signal (Liu and Maller, 2005; Madgwick et al., 2006; Rauh et al., 2005).58
Emi2 blocks APC/C
Cdc20 activity by directly binding to Cdc20, therefore allowing cyclin
B1 re-accumulation following the MI to MII transition, and so MPF reactivation, until
fertilization (Schmidt et al., 2005).
In frog eggs, the mechanism for establishment and maintenance of CSF arrest has just
been reported, with the authors proposing the existence of a link between the long-
standing CSF candidate c-Mos/MEK/MAPK/p90
rsk pathway and Emi2 (Inoue et al.,
2007; Nishiyama et al., 2007a; Tung et al., 2005). This study shows that in Xenopus
eggs, Emi2 is directly phosphorylated by the kinase p90
rsk resulting in recruitment of the
protein phosphatase 2A (PP2A) (Nishiyama et al., 2007a; Wu et al., 2007). PP2A in turn
dephosphorylates Emi2 at the MPF phosphorylation sites that would disrupt the
interaction between Emi2 and APC/C
Cdc20 (Wu et al., 2007). However, in contrast to
frog, the link between p90
rsk and Emi2 is unlikely to exist in mammalian eggs, given that
constitutively active mutant forms of Rsk fail to induce the Met II arrest when injected in
dividing mouse embryos or mos
-/- oocytes (Dumont et al., 2005). Moreover, eggs from
Rsk knockout mouse present normal CSF arrest (Dumont et al., 2005). Therefore, in
mouse eggs, p90
rsk might not be the downstream target of MAPK that is responsible for
phosphorylating Emi2 during Met II arrest.
Upon fertilization of frog eggs, Emi2 is targeted for degradation. This is achieved
through the Ca
2+ signals that are transduced by CaMKII, which in turn phophorylates
Emi2 and stimulates its association with the polo-like kinase, Plk1 (Hansen et al., 2006;
Liu and Maller, 2005; Lorca et al., 1993; Schmidt et al., 2005). This is followed by Plk1-59
mediated phosphorylation of Emi2 to generate a phosphodegron, which is then
recognised by the SCF-E3 ubiquitin ligase, resulting in polyubiquitination of Emi2 and
targeting for destruction by the proteasome (Hansen et al., 2006; Liu and Maller, 2005;
Rauh et al., 2005; Schmidt et al., 2005). The resultant Emi2 degradation unleashes the
APC/C
Cdc20 to initiate anaphase II and complete the second meiotic division (Hansen et
al., 2006; Liu and Maller, 2005; Rauh et al., 2005). This mechanism, however, has not
yet been confirmed in mammalian eggs. Although, mouse Emi2 was also found to
contain specific motifs for phosphorylation by Plk1 and CaMKII.
As well as CaMKII, the Ca
2+-dependent phosphatase calcineurin was proven to be
involved in the exit from CSF arrest (Mochida and Hunt, 2007; Nishiyama et al., 2007b).
Recently, it was reported that inhibition of calcineurin in the presence of Ca
2+, delays
cyclin B1 destruction and prevents exit from meiosis II (Mochida and Hunt, 2007;
Nishiyama et al., 2007b). Also, incubation of purified APC/C from CSF egg extracts
with calcineurin causes dephosphorylation of the APC/C core subunit (Apc3) and its co-
activator (Cdc20) (Mochida and Hunt, 2007). Therefore, these calcineurin-mediated
dephosphorylation events might be crucial for APC/C
Cdc20 activation and exit from CSF
arrest.
1.4.4. Resumption of meiosis II
Fertilization of the mammalian egg by sperm is associated with an explosive increase in
cytosolic Ca
2+, which is both necessary and sufficient to trigger resumption of meiosis II
following the metaphase arrest (Stricker, 1999). The Ca
2+ signal spreads through the egg60
in a wave, starting at the point of sperm entry. In contrast to frog, whose eggs have a
monotonic and short rise in Ca
2+iupon fertilization, mammalian eggs display a series of
low frequency Ca
2+ transients (oscillations) lasting for hours after sperm-egg fusion
(Jones, 2004). Ca
2+ oscillations were first demonstrated in fertilized mouse eggs by
Cobbold and colleagues in the early 1980s (Cuthbertson et al., 1981; Cuthbertson and
Cobbold, 1985). Using the Ca
2+ specific photoprotein aequorin they found that, the
fertilized egg generated a series of low frequency Ca
2+ oscillations that lasted for several
hours. Ca
2+ is released from the endoplasmic reticulum (ER), and its release is regulated
by ligand-gated ion channels. In other cells it is generally accepted that IP3 (inositol
1,4,5-triphosphate) is the major effector in releasing Ca
2+ via the IP3 receptor (IP3R)
channel (Ayabe et al., 1995; Berridge et al., 2000; Miyazaki et al., 1993; Runft et al.,
2002; Streb et al., 1983), and that IP3 production is mediated by enzymes of the
phospholipase-C (PLC) family through PIP2 (phophatidylinositol-4,5-bisphosphate)
hydrolysis (Jones and Nixon, 2000; Nuccitelli et al., 1993). However, in eggs, the
mechanism of IP3 production via PLC has been a matter of controversy. In brief, two
hypotheses have been put forth. The first involves the binding of the sperm to a G
protein-coupled receptor on the egg plasma membrane, which results in the activation of
PLC, and so IP3 synthesis (Halet et al., 2003; Jones, 2005; Nuccitelli et al., 1993). The
most compelling evidence is that microinjecting mRNA of a G protein coupled-receptor
into pig eggs induces their meiotic activation (Kim et al., 1998; Nuccitelli et al., 1993).
The second hypothesis involves a soluble sperm factor that is introduced into the egg
upon fertilization (Halet et al., 2003b; Jones, 2005; Nuccitelli et al., 1993; Swann,
1990a). The sperm factor theory was initially derived from experiments by Dale and61
colleagues in 1985 showing that microinjection of soluble cytosolic sperm extracts into
sea urchin eggs triggers the cortical reaction (Dale et al., 1985). This was further
supported by a study done by Swann, with the author proposing that injection of sperm
soluble factors into mammalian eggs results in fertilization-like Ca
2+oscillations (Swann,
1990).
Increasing evidence supports the latter of these scenarios, especially after the discovery
of the sperm-specific PLC isoform (PLC zeta / PLCζ), which was initially cloned from 
mouse testes library (Saunders et al., 2002).  It has been suggested that PLCζ is present at 
a sufficient concentration in the part of the sperm head that enters the egg first (Fujimoto
et al., 2004; Saunders et al., 2002).  It also has been reported that injection of PLCζ 
mRNA in mouse eggs generates Ca
2+ oscillations very similar to those caused by sperm
upon fertilization (Saunders et al., 2002), whereas other PLC isoforms were unable to
stimulate such oscillations (Mehlmann et al., 2001).  Moreover, depletion of PLCζ from 
sperm extracts removed their ability to induce Ca
2+ rise (Knott et al., 2005). Finally, a
recent study by Yoon et al also reported that human sperm lacking PLCζ is unable to 
initiate Ca
2+ oscillations upon sperm-egg fusion, therefore leading to failure to activate
the egg and sterility (Yoon et al., 2008). All these reports definitely support PLCζ as the 
most likely sperm factor candidate; however its physiological importance at fertilization
and during early embryo development remains to be demonstrated.
Whatever the exact mechanism, Ca
2+ signals are transduced by calmodulin, which in turn
associates with and activates calmodulin-dependent protein kinase II. Activation of62
CaMKII leads to degradation of cyclin B1 and securin through the APC/C. The resultant
cyclin B1 and securin destruction allows MPF inactivation and unleashes the protease
separase, to initiate anaphase and complete the second meiotic division (Lorca et al.,
1991; Lorca et al., 1993). In what follows, I will focus on the molecular mechanisms
underlying the regulation of separase activity, and on how cells ensure that cohesin
cleavage occurs at the right time and place, making possible the complete and accurate
distribution of their chromosomes.
1.5. Chromosome attachment and segregation
A fundamental aspect of cell division is the maintenance of genomic integrity through
accurate transmission of the duplicated genome into daughter cells. Errors in
chromosomal distribution lead to cells with supernumerary or missing chromosomes
(Hassold et al., 2007; Hassold and Hunt, 2001). The resulting aneuploidy is usually
associated with many cancers, and is also the leading cause of human birth defects (such
as trisomies), malformations of the embryo and spontaneous foetal abortions (Hassold et
al., 2007; Hassold and Hunt, 2001). In order to avoid chromosomal missegregation, the
products of DNA replication, the sister chromatids, are held together by the chromosomal
cohesin complex, which prevents them from drifting apart after synthesis (Nasmyth et al.,
2000; van Heemst and Heyting, 2000). This cohesion is also important in facilitating
DNA repair by homologous recombination throughout G2, and allowing chromosomes to
be aligned in the middle of the metaphase spindle and to be separated simultaneously at
anaphase onset (van Heemst and Heyting, 2000).63
1.5.1. Chromosome attachment: the cohesin complex
Newly replicated sister chromatids tend to remain linked by the cohesin complex from S-
phase until the metaphase-to-anaphase transition, when cohesion is dissolved (Nasmyth
et al., 2000; van Heemst and Heyting, 2000). This molecular glue, which is believed to
embrace both sisters in a ring-like structure, consists of five core subunits: two SMC
subunits that belong to the family of Structural Maintenance of Chromosome (Smc1 and
Smc3) and three non-SMC subunits (Scc1, Scc3 and Pds5) (Darwiche et al., 1999;
Guacci et al., 1997; Hartman et al., 2000; Losada et al., 1998; Michaelis et al., 1997;
Panizza et al., 2000; Sumara et al., 2000; Toth et al., 1999). The components of the
cohesin complex were first identified by genetic studies in yeast, in which they isolated
five genes whose mutagenesis caused premature sister chromatid separation and high
rates of chromosome loss (Michaelis et al., 1997; Panizza et al., 2000; Toth et al., 1999).
At anaphase onset, the resolution of sister chromatid cohesion is catalysed by the cysteine
protease, separase, which cleaves the Scc1 subunit (Uhlmann et al., 1999; Uhlmann et al.,
2000). Separase also triggers chromosomes separation during meiosis by cleaving the
Scc1 meiotic homolog (Rec8), which is believed to confer some specialized meiotic
purposes, such as formation of the synaptonemal complex, reciprocal recombination and
protection of centromeric cohesion (Deveaux and Smith, 1994; Klein et al., 1999; Lorenz
et al., 2004; Parisi et al., 1999). In plants and fission yeast, it has been reported that loss
of Rec8 results in disruption of the monopolar orientation of sister kinetochores, leading
to equational rather than reductional division during meiosis I, which cannot be rescued
by expression of Scc1 (Chelysheva et al., 2005; Watanabe and Nurse, 1999; Yokobayashi64
et al., 2003). This implies that the meiotic cohesin complex also plays a crucial role in
establishing the mono-orientation of the MI kinetochores.
1.5.2. Chromosome segregation: dissolving cohesion
In somatic cells and during mitosis, centromeric cohesin is lost at anaphase onset by the
protease separase (Uhlmann et al., 1999; Uhlmann et al., 2000; Waizenegger et al., 2000).
Cohesin bound to chromosome arms, however, is removed during early stages of mitosis
via the “prophase pathway” (Waizenegger et al., 2000). This mechanism does not
depend on separase-mediated Scc1 cleavage, but it does require the two mitotic kinases
Plk and Aurora B (Losada et al., 2002; Sumara et al., 2002). Accordingly, it was
demonstrated that Plk directly phosphorylates Scc1 and Scc3 in vitro (Sumara et al.,
2002). Also, phosphorylated cohesin when incubated with sperm chromatin associate
less efficiently to DNA than the non-phosphorylated one (Sumara et al., 2002).
Therefore, the release of the cohesin complexes during the prophase pathway might be
triggered by the phosphorylation of its two subunits (Scc1 and Scc3) by Plk. However,
the role of Aurora B in this process is less clear and requires further investigation.
In contrast to mitosis, during meiosis cohesins are lost in a stepwise manner and the
whole process is separase-dependent (Kudo et al., 2006; Lee et al., 2006). Removal of
cohesion from chromosome arms does not take place until anaphase I onset, hence
allowing homologs segregation during meiosis I (Lee et al., 2006). Whereas, centromeric
cohesin is only cleaved during anaphase II, leading to sister chromatid separation (Lee et
al., 2006).65
During meiosis I and mitotic prometaphase, protection of centromeric cohesin is achieved
by a specific cohesin protector, called shugoshin (Sgo), which means “guardian spirit” in
Japanese (Kitajima et al., 2004). Mammals have two shugoshin homologs, Sgo1 and
Sgo2, which are expressed in both somatic and germ cells. Nonetheless, Sgo1 is the key
protector of centromeric cohesin during mitosis, whereas the predominant role of Sgo2 is
during meiosis. Indeed, depletion of human Sgo1 causes removal of the whole bulk of
cohesin including the centromeric one during prometaphase, and knockdown of Sgo2 in
mouse oocytes results in loss of centromeric cohesion and separation of sister chromatids
by the time the oocytes enter metaphase II (Kitajima et al., 2004; Kitajima et al., 2005;
Lee et al., 2008; Llano et al., 2008; McGuinness et al., 2005; Tang et al., 2004).
Recruitment of shugoshin to the centromeric region of chromosomes is catalysed by the
SAC protein Bub1, which also promotes shugoshin association with the protein
phosphatase PP2A (Kitajima et al., 2005; Kitajima et al., 2006; Tang et al., 2004). The
Sgo/PP2A complex, in turn, induces the dephosphorylation of centromeric cohesin, thus
preventing its cleavage and dissociation from the chromatin (Kitajima et al., 2006; Riedel
et al., 2006). Accordingly, it was reported that purified Sgo/PP2A complexes are able to
dephosphorylate the cohesin subunits Scc1 and Scc3 that have been phosphorylated by
Plk in vitro (Kitajima et al., 2006). Also, inactivation of PP2A in yeast and mouse
oocytes causes premature sister chromatid separation and higher rate of aneuploidy (Lee
et al., 2008; Mailhes et al., 2003; Riedel et al., 2006). At anaphase onset, the Sgo/PP2A
complex is displaced away from the centromeres as a result of the microtubule pulling66
tension generated across the sister kinetochores, therefore allowing phosphorylation of
the centromeric cohesin by Plk, which seems to be crucial for cohesin cleavage by
separase (Gomez et al., 2007).
1.5.3. Separase
1.5.3.1. Structure and function of separase
Separase was initially identified in a mutant form of fission yeast, in which cell division
occurs in the absence of nuclear division, causing the cut (cell untimely torn) phenotype
(Hirano et al., 1986). Separase homologs exist in most if not all eukaryotes examined so
far, and its name varies from one organism to another: CUT1 in fission yeast, ESP1 in
budding yeast and separin/separase in human (Hirano et al., 1986; Mcgrew et al., 1992;
Nagase et al., 1996).
Separases are generally large proteins of 150-230 kDa, and only a C-terminal domain
seems to be conserved amongst them. This conserved domain, the separin domain,
contains the signature motif for the cysteine endopeptidases of the CD-clan subclass, a
superfamily of proteases that also includes the caspases, which are involved in
programmed cell death (Aravind and Koonin, 2002; Uhlmann et al., 2000). The N-
terminal region of separase, however, does not show obvious conservation between
species (Hornig et al., 2002). This large region is believed to be the site of interaction
with separase’s binding partner, securin (Hornig et al., 2002).67
Figure 1.8. Cohesin cleavage during mitotic and meiotic cell divisions.
(A) In somatic cells and during mitosis, cohesin complexes bound to chromosomes arms
are removed during prometaphase via the prophase pathway, which involves Plk and
Aurora B-mediated phosphorylation of cohesin. Centromeric cohesin, however, is
protected from prophase dissociation by the Shugoshin/PP2A complex. At anaphase
onset and as a result of the displacement of the Shugoshin/PP2A complex, centromeric
cohesin is destroyed by separase, leading to sister chromatid separation. (B) In contrast
to mitosis, during meiosis cohesin is lost in a stepwise manner and the whole process is
separase-dependent. During meiois I, only cohesion from chromosomes arms is lost,
while centromeric cohesin is protected by Shugoshin/PP2A, therefore only allowing
homologs separation at anaphase I. In meiosis II, the Shugoshin/PP2A complex is moved
away from the centromeres vicinity, thus resulting in centromeric cohesin cleavage by
separase and sisters’ segregation during anaphase II.68
In yeast, it was reported that esp1 mutants fail to dissociate Scc1 from their chromosomes
and are completely defective in sister chromatid separation, whereas in the wild type cells
Scc1 suddenly disappears from the chromosomes at anaphase onset (Ciosk et al., 1998;
Michaelis et al., 1997). Also, it was demonstrated that budding yeast and human
separases are capable of cleaving Scc1 in vitro, and the Scc1-derived peptide inhibitor
binds the active site of yeast separase (Uhlmann et al., 2000; Waizenegger et al., 2000).
These observations confirm the hypothesis that separase triggers chromosomes
segregation through removal of cohesin, which solely relies on Scc1 cleavage. Indeed,
separase recognises and cleaves the Plk-phosphorylated Scc1 at two distinct sites, each
with an arginine residue (Uhlmann et al., 1999). Mutation of either site does not abolish
the cleavage of Scc1, whereas simultaneous mutation of both arginines does, leading to
lethality (Uhlmann et al., 1999).
The universal role of separase in triggering anaphase and chromosomes segregation
through cohesin cleavage is an irreversible step, once executed it cannot be undone. This
suggests that separase must be highly regulated by surveillance mechanisms that allow its
activation and progression of the cell cycle into anaphase only if the cells are sure that
their DNA is damage-free and chromosomes are properly attached to the spindle
microtubules.
1.5.3.2. Separase regulation
The best-known regulator of separase is securin, which is a functionally conserved
protein, although there is little conservation of its primary amino acid sequence except for69
the presence of D-box and KEN-box motifs (Ciosk et al., 1998; CohenFix et al., 1996). It
was originally identified in budding yeast as Pds1, whose depletion results in precocious
separation of sister chromatids and increased rates of chromosome loss (Ciosk et al.,
1998; Yamamoto et al., 1996). Securin, also known as the product of the pituitary
tumour-transforming gene (PTTG) in vertebrates, CUT2 in fission yeast and PIM in
Drosophila, binds to and inhibits separase for most of the cell cycle, but at metaphase
onset it is targeted for degradation via ubiquitination by the APC/C, thus unleashing
separase (Funabiki et al., 1996a; Funabiki et al., 1996b; Leismann et al., 2000; Pei and
Melmed, 1997; Stratmann and Lehner, 1996).
In fission yeast and Drosophila, securin is essential for chromosomes disjunction and its
absence leads to impairment in separase activity and failure in separating sister
chromatids, suggesting that securin must be more than a simple inhibitor of separase
(Funabiki et al., 1996b; Jensen et al., 2001; Leismann et al., 2000). Indeed, it was
recently reported that securin inhibits the proteolytic activity of separase in a 2-fold
manner (Funabiki et al., 1996a; Hornig et al., 2002). While inhibiting separase, securin is
able to promote the spindle localization of the protease, and securin destruction then
promotes the full activation of separase at anaphase (Hornig et al., 2002; Kumada et al.,
1998). The specific architecture of the separase-securin complex is believed to be at the
origin of this dual mechanism of regulation. Securin binds to both the N and C terminus
of separase leading to their separation and therefore preventing them from inducing an
activating conformational change at the protease active site (Hornig et al., 2002). Upon
securin degradation at anaphase onset, the N and C terminus are free to interact and70
therefore to induce the conformational change that is necessary for the activation of
separase (Hornig et al., 2002).
Many studies have demonstrated the importance of securin degradation for normal
anaphase. In frog eggs, it was demonstrated that over-expression of non-degradable
securin results in failure to separate chromosomes (Zou et al., 1999). A similar
phenotype was observed in human somatic cells upon the expression of stable securin
(Hagting et al., 2002). However, despite its crucial role as an inhibitor of separase, it is
not essential for viability of budding yeast, and for maintaining cohesion in mammals
(Waizenegger et al., 2002; Yamamoto et al., 1996). It also has been reported that securin
knockout mice are viable and fertile, and human cultured cells lacking securin execute
mitosis normally (Huang et al., 2005; Waizenegger et al., 2002). This suggests that other
securin-independent mechanisms must contribute to the control of separase. Regulation
of phosphorylation of the Scc1 subunit of cohesin (Rec8, in meiosis) could be one such
mechanism (Holland and Taylor, 2006; Waizenegger et al., 2002). Shugoshin-dependent
protection of centromeric cohesin could be another mechanism (Kitajima et al., 2004).
Also, recruitment of cyclin B1 by phosphorylated separase is an additional mechanism.
It was reported that CDK1-mediated phosphorylation of separase is required for the
stable binding of CDK1 to separase via its regulatory subunit cyclin B1, leading to
inhibition of both protease and kinase (Gorr et al., 2005), which seems to be crucial for
PB1 extrusion and exit from meiosis I in mouse oocytes (Gorr et al., 2006). In vitro and
in vivo studies showed that non-degradable cyclin B1 blocks anaphase and chromosomes
separation, which could be rescued by mutating the CDK1 phosphorylation sites in71
separase (Chang et al., 2003; Herbert et al., 2003; Stemmann et al., 2001). Also,
incubation of separase with CDK1 leads to separase inactivation despite the absence of
securin (Gorr et al., 2005). CDK1 and securin are unable to bind separase
simultaneously; therefore the loss of one inhibitory mechanism is expected to be
compensated by the other. Indeed, a recent study demonstrated that ES cells lacking
either the securin- or CDK1-separase inhibition mechanism maintained sister chromatid
cohesion (Huang et al., 2005).
Finally, vertebrate separase itself undergoes auto-cleavage at anaphase (Papi et al., 2005).
The consequences of this cleavage in mitosis have just been described, with the authors
suggesting that the cleaved separase acts positively to induce entry into the next mitotic
cell cycle (Papi et al., 2005). This is believed to be achieved through promoting the
destruction of the kinase Wee1, therefore leading to pre-MPF activation during late G2
(Papi et al., 2005). This hypothesis, however, remains to be tested during the meiotic cell
cycle.72
Chapter 2: Materials & Methods
2.1. Materials
Female MF1 mice were obtained from Harlan (UK). Mouse oocyte collection and
culture equipment was from VWR (UK), unless stated otherwise. All chemicals were
purchased from Sigma-Aldrich (UK), unless noted otherwise. Antibodies were obtained
from AbCam (UK). All antisense morpholinos (MO) were designed by Genetools
(USA).
All chemicals used were tissue culture or embryo-tested grade where appropriate.
2.2. Methods
2.2.1. Mouse oocyte collection and culture
2.2.1.1 Collection of germinal vesicle oocytes
Germinal vesicle (GV) oocytes were collected from 4-6 weeks old MF1 mice
(Harlan). The females were superovulated by intraperitoneal injection of 7.5IU of
pregnant mares’ serum gonadotrophin (PMSG) (Calbiochem), which mimics
endogenous FSH. Mice were killed by cervical dislocation at 46-48 h after
PMSG injection. The ovaries were removed and immediately transferred to
dissection medium, consisting of M2 medium (Table 1) supplemented with 1µM
milrinone or 200µM IBMX, in order to keep the oocytes arrested at the GV stage.
The cumulus-enclosed oocytes were isolated by mechanical perforation of the
ovaries with a 27-gauge needle. The cumulus masses were removed by repeated73
mouth-pipetting, using narrow-bore glass Pasteur pipettes. Following few rinses
in drops of dissection medium, the oocytes were ready for further use.
2.2.1.2 Collection of metaphase II-arrested eggs
For collection of Met II eggs, 4-6 weeks old MF1 mice were superovulated by
intraperitoneal injection of 7.5IU of PMSG, followed 46-48 h later by 5IU of
human chorionic gonadotrophin (hCG) (Calbiochem), which has strong homology
with LH. Mice were killed by cervical dislocation at 13-15 h after hCG injection.
The oviducts were removed and immediately transferred to M2 medium. The
oviducts were then placed in M2 medium containing 300IU/ml hyaluronidase.
The cumulus-enclosed Met II eggs were released using fine forceps to tear the
oviducts. Following a brief exposure to hyaluronidase (maximum 5 min), the
cumulus cells were removed. The denuded Met II eggs were then washed in M2
medium and ready for further manipulations.
For bench handling, microinjections and imaging experiments, GV and Met II oocytes
were cultured in M2 medium. For longer-term incubation, the oocytes were cultured in
minimum essential medium (MEM) (Gibco) supplemented with 20% of foetal bovine
serum (FBS) (Invitrogen), 60µg/ml penicillin and 50µg/ml streptomycin in a 5% CO2
humidified incubator at 37ºC (Lab Impex Research). To keep the GV oocytes arrested,
the culture media (M2 or MEM) was supplemented with 1µM milrinone or 200µM
IBMX. For parthenogenetic activation of eggs, the Met II-arrested oocytes were
incubated in Sr
2+ medium (Table 2).74
Table 1: Composition of M2 culture medium
M2 was used for oocytes collection and short term culture. This is a modified Kreb’s
Ringer solution with some of the bicarbonate substituted with Hepes buffer.
Component Concentration (mM)
NaCl 94.66
KCl 4.78
CaCl2.2H20 1.71
KH2.PO4 1.19
MgSO4.7H20 1.19
NaHCO3 4.15
Hepes 20.85
Na Lactate 23.28
Na Pyruvate 0.33
Glucose 5.56
BSA 4.00g/l
Penicillin G. K salt 0.06g/l
Streptomycin sulphate 0.05g/l
Phenol Red 0.01g/l75
Table 2: Composition of Sr
2+ medium
Sr
2+ medium was a used for parthenogenetic activation of eggs. This is a Ca
2+-free M2
medium with CaCl2.2H20 replaced by SrCl2. BSA was added right before usage.
Component Concentration (mM)
NaCl 94.66
KCl 4.78
SrCl2 10
KH2.PO4 1.19
MgSO4.7H20 1.19
NaHCO3 4.15
Hepes 20.85
Na Lactate 23.28
Na Pyruvate 0.33
Glucose 5.56
BSA 4.00g/l
Penicillin G. K salt 0.06g/l
Streptomycin sulphate 0.05g/l
Phenol Red 0.01g/l76
2.2.2. Microinjection and imaging
All microinjections of GV and Met II oocytes were done in M2 medium (± milrinone or
IBMX) on the heated stage of an inverted microscope (Leica DM IRB, Leica, Wetzlar,
Germany). Borosilicate glass capillaries (outer diameter 1.5mm and inner diameter
0.86mm) with an inner filament (Harvard Apparatus Ltd) were used to make
microinjection pipettes using a micropipette puller (Model P-97, Sutter Instrument,
USA). The micropipettes were then backfilled with approximately 1µl of injection
solution, and inserted into oocytes using the negative capacitance overcompensation
facility on an electrophysiological amplifier (World Precision Instruments, UK); while
cells were immobilised with a holding pipette (Hunter Scientific). This procedure
ensures a high rate (>90%) of oocytes survival and a low rate (<1%) of Met II oocytes
parthenogenetic activation. A precise injection volume (2-5% of the total oocyte volume)
was achieved by using a Pneumatic PicoPump (World Precision Instruments). The
volume of the oocyte is approximately 250pl.
Brightfield and epi-fluorescence images were recorded using a (20 X 0.75 NA) objective
and a Princeton Instruments MicroMax interline cooled CCD camera (Roper Scientific,
Buckinghamshire, UK). Filters sets were used as appropriate for the fluophore being
studied. Hoechst staining, for example, was examined using a UV filter set at BP 330-
380 nm for excitation, DM 400 nm and LP 450 nm for emission. Whereas, GFP and YFP
tagged proteins were imaged using a fluorescein isothiocyanate (FITC) filter set at BP
450-490 nm for excitation, DM 510 nm and BP 520 nm for emission. Metamorph (MM)
and metafluor (MF) software 6.1 (Universal Imaging Corp, PA, USA) were used for77
image capture (control of the filter and shutter settings) and data analysis. Eggs were
imaged every 10-20 minutes to minimise photobleaching and photodamage. Also, to
accurately measure multiple oocytes within a single image, it was important to correct the
illumination variation across the field of view. This was done using the Metamorph’s
“Reference Image” command, which allows the acquisition of a background image with
the same experimental conditions as the sample image (wavelength and exposure time)
but with a closed-shutter. The background was then subtracted from the experimental
image, therefore improving quantitative accuracy and overall throughput.
2.2.3. Western blotting
Oocytes were washed in phosphate-buffered saline (PBS) with 1% polyvinylpyrrolidone
(PVP) solution and frozen in 5X sample buffer (0.06M Tris/HCL at pH 6.8, 2% sodium
dodecyl sulphate (SDS), 10% glycerol, 0.025% bromophenol blue and 5% 2-
mercaptoethanol). The samples were then boiled at 95ºC for 5 min using a heat block
(QBT2, Grant) and briefly centrifuged at 8,000Xg (MSE, Micro Centaur, Sanyo, Japan).
Proteins were fractionated at 200mV for 50 min on an X Cell II™ blot Module
(Invitrogen) and power pack (Power Pac 300, BioRad); using 10% NuPage Bis-Tris pre-
cast gels (Invitrogen) with mopholinepropanesulphonic acid (MOPS) running buffer
(Invitrogen). Coloured standard markers (Kaleidoscope, BioRad) were also loaded on
the gel. Following electrophoresis, proteins were blotted onto polyvinylidened fluoride
membranes (PVDF) for 1h30min at 100mV. The PVDF membranes used were pre-
rinsed in 100% methanol, washed in water and then placed in blotting buffer (25mM Tris78
buffer, 192mM glycine, 20% methanol). Following blotting, the membranes were
saturated with 5% non-fat dry milk in blocking buffer (10mM Tris, 100mM NaCl and
0.1% Tween-20) at room temperature for 1h and incubated with primary antibody (Table
3) overnight at 4°C. After the overnight incubation, membranes were washed in blocking
solution without milk for 1 h with buffer changed every 15 min, then incubated with anti-
rabbit/mouse horseradish peroxidise (HRP)-linked secondary antibody (Table 4) for 1h at
room temperature. Finally, membranes were washed again in blocking buffer for 1h with
continuous change of buffer.
Standard enhanced chemiluminescence (ECL) techniques (Amersham Biosciences) were
used to detect the protein-bound HRP-labelled secondary antibodies according to the
manufacturer’s instructions. The membranes were incubated in ECL detection solution
mixture (40:1), wrapped in Clingfilm and exposed to Hyperfilm (Amersham
Biosciences). The exposure time depended on the strength of the signal.79
Table 3: Primary antibodies used in this study.
Primary antibody Species Concentration Manufacturer
&
catalogue number
Anti-securin Mouse 1:1000 AbCam (ab3305)
Anti-cyclin B1 Mouse 1:400 AbCam (ab72)
Anti-Cdh1 Mouse 1:200 AbCam (ab3242)
Anti-Cdc20 Rabbit 1:200 Santa Cruz (sc-8358)
Anti-PLK1 Rabbit 1:500 AbCam (ab14209)
Anti-actin Mouse 1:2500 Millipore (MAB1501R)
Table 4: Secondary antibodies used in this study.
Secondary antibody Concentration Manufacturer
&
catalogue number
Goat anti-mouse 1:5000 BioRad (170-6516)
Goat anti-rabbit 1:5000 BioRad (172-1019)
2.2.4. Chromosome spreads
Chromosome spreads were prepared by the air-drying technique, which involves swelling
eggs, fixing them on slides and staining them with Giemsa. Eggs’ swelling was done
through incubation in a dish filled with 1% trisodium citrate for 7-10 min. The eggs were
then placed onto clean microscope slides and immediately fixed by dropping onto them80
one drop of freshly prepared fixative, 3:1 (Methanol:glacial acetic acid), from a height of
at least 2 cm to avoid premature fixation by vapour. Following fixation, the
chromosomes were spread by gentle mouth blowing, and left to dry overnight. The slides
were then incubated for 5 min in 5M HCL, washed with running distilled water and
stained with 9:1 (Gurr buffer:Giemsa). Finally, the slides were rinsed in Gurr buffer (pH
6.8 - BDH) and left to dry.
C-spreads, however, were prepared by treating the fixed oocytes with 0.2M HCL for 1 h,
and then incubating the slides in a freshly prepared aqueous solution of 4% barium
hydroxide at 37°C for 30 seconds. This was followed by a subsequent incubation in 2 x
standard saline citrate (SSC; 0.3M sodium chloride/0.03M trisodium citrate) at 60°C for
1 h, and Giemsa staining for 15 min. Slides were rinsed in distilled water following each
step.
To visualise the chromatin, the slides were applied to a microscope (TE300, Nikon). (20
X 0.75 NA) objective was used to find the chromatin and (100 X 0.75 NA) oil immersion
lens was used to count the chromosomes and to record brightfield images of the spreads,
as previously described.
2.2.5. H1 kinase assay
MPF (CDK1-cyclin B) activity can be measured in vitro by its ability to phosphorylate
histone H1. Five oocytes collected in 2µl of PBS were transferred in 3µl of storing
solution (10µg/ml leupeptin, 10µg/ml aprotinin, 10mM p-nitrophenyl phosphate, 20mM81
β-glycerophosphate, 0.1mM sodium orthovanadate and 5mM EGTA), and immediately
frozen on dry ice. After three thaw-freeze cycles, 2 x concentrated kinase buffer
[60µg/ml leupeptin, 60µg/ml aprotinin, 24mM p-nitrophenyl phosphate, 90mM β-
glycerophosphate, 4.6mM sodium orthovanadate, 24mM EGTA, 24mM MgCl2, 0.2mM
EDTA, 4mM MOPS, 0.6mM ATP, 2mg/ml histone H1 (HIII-S from calf thymus,
Sigma) and 0.25mCi/ml [
32P] ATP] was added to the samples. This was followed by 30
min incubation at 30°C. The reaction was then stopped by addition of 2 x SDS-sample
buffer (0.125M Tris-HCL, 4% SDS, 20% glycerol, 10% mercaptoethanol, 0.002%
bromophenol blue). The samples were then boiled at 95°C for 3-5 min, analysed by 10%
SDS-PAGE gel at 7V for 18h (Table 5), which was followed by autoradiography.
Autoradiographs were imaged using Fuji Bas-1000 phosphorimager system and analysed
with TINA 2.0 software.
Table 5: 10% SDS-PAGE gel
The stacking gel was applied to the separating gel following solidification
Separating gel 10%
40% acrylamide 24ml
2% Bis-acrylamide 13ml
1.5M Tris-HCl pH8.8 25ml
10% SDS 1ml
10% APS (1g/ml) 500µl
TEMED 50µl
Water ↑ 100ml
Stacking gel 4%
40% acrylamide 3ml
2% Bis-acrylamide 1.5ml
0.5M Tris-HCl pH8.8 7.5ml
10% SDS 300µl
10% APS (1g/ml) 150µl
TEMED 30µl
Water ↑ 30ml82
2.2.6. Protein knockdown using morpholino antisense oligos
To better understand the role of securin, cdc20 and cdh1 in the control of meiosis, I have
decided to deplete them using morpholino oligonucleotides (MO) (Table 6).
Morpholinos prevent protein translation by binding to their complementary sequences in
the 5’ untranslated region of target mRNA, therefore blocking access of the translation
initiation complex. Unlike other antisense oligos (e.g. siRNA and sDNA), morpholinos
are completely stable to nucleases, non-toxic, water soluble and have very long-term
activity. Those criteria are due to key structural features, with morpholine rings replacing
the ribose sugars in the DNA bases (A, T, G and C) and non-ionic inter-subunit linkages
replacing the anionic phosphates (www.gene-tools.com). To achieve very high sequence
specificity, morpholinos tend to be 20-25 bases long, which assures strong and specific
binding to their complementary target sites. Like all gene knockdown reagents,
morpholinos were actively delivered into GV oocytes through microinjection. The
oocytes were then cultured for 24 h in MEM supplemented with milrinone or IBMX, in
order to keep them arrested at the GV stage. To resume maturation, the oocytes were
incubated in MEM following release.83
Table 6: Morpholinos used and their sequences.
2.2.7. Preparation of RNA for microinjection
2.2.7.1. Bacteria transformation and plasmid DNA purification
To propagate a plasmid carrying the gene of interest, 10pg-100ng of plasmid
DNA was transformed into 50µl of TOP10 chemically competent E.coli cells.
The cells were then incubated on ice for 30 min, followed by a brief heat-shock
for 30 seconds at 42C before being placed back on ice for 2 min. 250µl of pre-
warmed S.O.C. medium (GIBCO) was then added to the cells, which were further
incubated for 1 h at 37C. The transformation reaction was then spread on agar
plates containing 100µg/ml ampicillin and incubated overnight at 37C. After the
incubation, single colonies were picked and grown overnight at 37C in LB
medium (Sigma) containing 100µg/ml ampicillin. The cells from the overnight
culture were then collected by centrifugation for 5 min at 10,000Xg and the
plasmid DNA was purified using QIAprep Spin Miniprep Kit (QIAGEN)
according to the manufacturer’s instructions. Finally, the presence of the plasmid
DNA within the collected sample was confirmed by agarose gel electrophoresis
Morpholino Sequence (5’ → 3’) Concentration
Securin MO GATAAGAGTAGCCATTCTGGATTAC 1.5mM
5MM-securin MO GATAACACTACCGATTCTCGATTAC 1.5mM
Cdh1 MO CCTTCGCTCATAGTCCTGGTCCATG 3.0mM
Cdc20 MO CGGTCTCAAACACCAAGTGCGGCAT 3.0mM84
and its concentration was measured using NanoDrop spectrophotometer (ND
1000, Thermo Scientific).
2.2.7.2. Synthesis of RNA
Plasmid DNA used in this thesis contained T3 RNA polymerase promoter site and
therefore mMESSAGE mMACHINE T3 Ultra kit (Ambion) was used for RNA
synthesis. The template DNA was first linearised with the restriction enzyme sfiI,
analysed on agarose gel and purified using QIAquick Gel Extraction Kit
(QIAGEN) according to the manufacturer’s instructions. After linearization, the
plasmid DNA was incubated with T3 RNA polymerase enzyme mixture, reaction
buffer and ribonucleotides for 3 h at 37°C. This was followed by addition of 1µl
of TURBO DNase, which removes the template DNA, and further incubation at
37°C for 15 min. Once the reaction was completed, RNA poly(A) tailing was
done by adding the tailing reagents (E-PAP enzyme, E-PAP buffer, MnCl2 and
ATP solution) to the mMESSAGE mMACHINE T3 Ultra reaction and incubating
it at 37°C for 90 min. Finally the RNA was purified and cleaned up from the
transcription reaction using RNeasy Mini Kit (QIAGEN) according to the
manufacturer’s instructions. The recovered RNA was then run on agarose gel and
quantified using NanoDrop spectrophotometer (ND 1000, Thermo Scientific),
before being aliquoted into 1 µl aliquots and stored at -80C until further use.85
2.2.7.3. Agarose gel electrophoresis
Agarose gel electrophoresis was used to check the size and quantity of purified
DNA or RNA. 0.8% agarose gel was prepared by mixing 0.4g of agarose powder
with 50ml of 1 x Tris-acetate-ethylenediaminetetracetic acid (EDTA) (TAE
buffer) (Promega). The mixture was boiled in a microwave oven until the agarose
powder has completely dissolved. 10mg/ml of ethidium bromide was then added
to the agarose-TAE buffer, and poured into a gel casting apparatus (BioRad).
Once the gel has set, it was placed in a BioRad mini-sub filled with 1 x TAE
buffer. The DNA and RNA samples mixed with loading buffers (DNA blue
loading dye and RNA formaldehyde loading buffer) were loaded onto the gel
alongside a 1kb DNA ladder (Promega) as a molecular weight indicator. The gel
was run for 20-30 min at 100V using a BioRad Power Pac 300, and finally
visualised on a UV transilluminator (TFX-20M, Vilber Lourmat).
2.2.8. Site-directed mutagenesis
Site-specific mutation and amino acid substitution in a plasmid carrying the gene of
interest was done using the QuikChange II site-directed mutagenesis kit (Stratagene).
This system utilises a double-stranded DNA vector with an insert, two mutagenic
oligonucleotide primers and a high fidelity PfuUltra DNA polymerase. The
oligonucleotide primers were carefully designed using Stratagene’s web-based
QuikChange primer design program (www.startagene.com/qcprimerdesign); such that
each primer was complementary to the opposite strand of the vector and carried in the
middle the desired mutation, which was flanked by 10-15 bases of correct sequence on86
both sides (Table 7). The mutagenesis was done in three steps, according to the
manufacturer’s instructions. Briefly, the first step was to synthesise the mutant strand,
which required oligonucletoide primers extension by PfuUltra DNA polymerase during
temperature cycling (Table 8). This was followed by Dpn I endonuclease treatment for
1h at 37C to digest the methylated parental DNA template and to select for mutation
containing synthesised DNA. Finally, the plasmid DNA carrying the desired mutation
was transformed into XL1-Blue supercompetent cells and purified using Miniprep DNA
purification system (section 2.7.1). To confirm the presence of the mutation, 50ng/µl of
plasmid DNA together with sequencing primer (Table 9) was sent to UCL scientific
support services for sequencing. The mutant plasmid DNA was then used as template for
RNA synthesis (section 2.2.7.2).87
Table 7: Mutagenic primers
Table 8: Cycling parameters for site directed mutagenesis
* Plasmid used in this study was 4.6 kb long; therefore it required 5 minutes at 68C per
cycle.
Primer Orientation Sequence (5’ → 3’)
Forward GCCTTAGATGGGAGATCTGAAGTTGCAGCACCACGTTTTGG
Securin T43A
Reverse CCAAAACGTGGTGCTGCAACTTGAGATCTCCCATCTAAGGC
Forward GCTGGGCCCCCCTGCACCTGTGAAGATGCCC
Securin S165A
Reverse GGGCATCTTCACAGGTGCAGGGGGGCCCAGC
Forward CCTGTGAAGATGCCCGCTCCACCATGGGAATCC
Securin S171A
Reverse GGATTCCCATGGTGGAGCGGGCATCTTCACAGG
Forward GCCTTACCTAAAGCTACTGCAAAGGCTTTGGGAACTGTC Securin
DM
RXXLAXXL Reverse GACAGTTCCCAAAGCCTTTGCAGTAGCTTTAGGTAAGGC
Forward GCTACTGCAAAGGCTGCGGGAACTGTCAACAGAGC Securin
DM
AXXLAXXA Reverse GCTCTGTTGACAGTTCCCGCAGCCTTTGCAGTAGC
Segment Temperature Time Cycles
1 Initial denaturation 95C 30 seconds 1
Denaturation 95C 30 seconds
Annealing 55C 1 minute
2
Extension 68C
5 minutes (1
min/kb of plasmid
length)*
16
3 Hold 37C -- 188
Table 9: Sequencing primer
2.2.9. Statistical analysis
All t-tests are two-tailed and based on two samples (unpaired) with similar variance. All
error bars represent standard deviations (SD).
Table 10: P values and their statistical significance.
P value Significance Symbol
>0.05 Not significant NS
0.01-0.05 Significant *
0.001-0.01 Very significant **
<0.001 Extremely significant ***
Primer Sequence (5’ → 3’)
Sequencing primer GGAAAATGGAGAACCAGGCACCC89
Table 11: Reagents used in this study.
Reagent Concentration Function
Milrinone 1 M Inhibition of GVBD
IBMX 200 M Inhibition of GVBD
SrCl2 10 mM Parthenogenetic activation
Hoechst 10ng/ml Staining of the Chromatin
Roscovitine 50 M CDK1 inhibitor
UO126 50 M MEK1 inhibitor
MG132 50 M Proteasome inhibitor
Cycloheximide 10 M Protein synthesis inhibitor90
Chapter 3: Securin and not MPF regulates sister chromatid
disjunction during meiosis II in mouse eggs.
3.1. Introduction
On completion of the first meiotic division, the mammalian oocyte enters the second
meiotic division and becomes arrested at the Met II stage until fertilization. This arrest is
due to the cytoplasmic activity, CSF, which stabilizes cyclin B1 by inhibiting the APC/C
(Tunquist and Maller, 2003). At fertilization, the sperm-triggered Ca
2+ oscillations induce
CSF inactivation, which in turn results in the stimulation of the APC/C, followed by
cyclin B1 and securin targeted destruction by the proteasome (Runft et al., 2002). The
degradation of cyclin B1 is necessary for MPF inactivation, hence release from the
metaphase II arrest and completion of meiosis II. Securin destruction, on the other hand,
is required for separase activation and sister chromatid separation at anaphase II.
During metaphase II arrest, which might last several hours, the egg has the difficult task
of ensuring the continued attachment and bi-orientation of the sister chromatids. This is
very important, because any premature loss of sister chromatid cohesion might lead to
aneuploidy, which is the leading cause of human birth defects (such as trisomies),
malformations of the embryo and spontaneous foetal abortions (Hassold and Hunt, 2001).
The maintenance of the pairing of sister chromatids during metaphase II arrest is
achieved through inhibition of separase, the protease that is responsible of cleaving the
cohesin complex, which holds chromatids together (Petronczki et al., 2003).91
It is well established that separase is regulated by two mechanisms, securin and
CDK1/cyclin B1 (Ciosk et al., 1998; Petronczki et al., 2003; Zou et al., 1999). They both
bind to and inhibit separase for most of the cell cycle until anaphase onset, when securin
and cyclin B1 are targeted for destruction via ubiquitination by the APC/C. Securin
inhibits separase by binding to both separase’s N and C terminus, therefore preventing
them from inducing an activating conformational change at the protease active site
(Hornig et al., 2002). MPF, on the other hand, only binds to CDK1-phosphorylated
separase via its regulatory subunit, cyclin B1, leading to the reciprocal inhibition of both
protease and kinase (Gorr et al., 2005; Holland and Taylor, 2006; Stemmann et al., 2001).
The two inhibitory mechanisms are mutually exclusive at the molecular level, given that
separase only binds one inhibitor at a time (Gorr et al., 2005). This implies that the loss
of one inhibitory mechanism could be compensated for by the other, and activation of
separase would require the loss of both mechanisms. Indeed, during the first meiotic
division of mouse oocytes separase activity is regulated by both securin and cyclin B1,
and proteolysis of both proteins is required for separase activation and homologue
disjunction (Herbert et al., 2003). This was demonstrated by over-expression of either
non-degradable D-box-truncated form of cyclin B1 (90-cyclin B1) or non-degradable
D-box mutated variant of securin, which were shown to inhibit both homologue
disjunction and polar body formation (Herbert et al., 2003). However, the relative
contribution of securin and cyclin B1 to separase inhibition and sister chromatid
attachment during the metapahse II arrest is not fully understood. Although, it was
reported that following fertilization sister chromatid separation was blocked upon over-92
expression of either 90-cyclin B1 or D-box mutant securin (Madgwick et al., 2004).
These observations, however, fail to give any context to the importance of securin and
cyclin B1 in the inhibition of separase, especially since sister chromatid separation
eventually occurs at later stages in the 90-cyclin B1 injected eggs (Madgwick et al.,
2004).
This study is set out to examine what controls separase during the metaphase II arrest of
mouse oocytes. I used the CDK1 inhibitor roscovitine and an antibody designed to block
the interaction of MPF with separase (Gorr et al., 2006), to demonstrate that separase is
not regulated by MPF during the metaphase II arrest. Instead, securin knockdown using
an antisense morpholino induces sister chromatid separation, which could be rescued by
injection of securin cRNA. Therefore, securin and not CDK1/cyclin B1 regulates
separase activity during metaphase II arrest.
3.2. Results
3.2.1 Exogenous cyclin B1 and securin show equal stability during Met II arrest
To determine the relative contribution of cyclin B1 and securin to separase inhibition
during the Met II arrest, I performed timelapse fluorescence measurements of oocytes
injected with cRNA constructs for yellow fluorescent protein (YFP) tagged cyclin B1
(cyclin B1-YFP) or securin (securin-YFP) during maturation, from GV to Met II arrest.
The measurements demonstrated that both proteins gradually accumulated during meiosis
I, declined at the time of PB1 extrusion, then increased again following entry into meiosis93
II (Fig. 3.1A, B). To establish whether cyclin B1 and securin are equally stable during
the Met II arrest, I calculated the mean rate of their re-expression in eggs two hours after
PB1 extrusion (Fig. 3.1C). There was no statistical difference between cyclin B1 and
securin fluorescence rises following entry into meiosis II. These results suggest that
exogenous cyclin B1 and securin are equally stable during metaphase II arrest.
3.2.2 Endogenous cyclin B1 and securin expression varies after PB1 extrusion
Having shown the equal stability of exogenous cyclin B1 and securin during Met II
arrest, I went on to examine the changes in the endogenous proteins using Western
blotting. An equal number of oocytes at different maturation stages and following arrest
at Met II, were blotted for cyclin B1 and securin (Fig. 3.2A). Similar to their YFP-
labeled constructs, cyclin B1 and securin levels increased during maturation, reaching
their highest point at metaphase I. This was followed by a period of intense degradation,
ending with PB1 extrusion. However, following polar body extrusion very marked
differences in the re-establishment of endogenous cyclin B1 and securin were observed.
Cyclin B1 levels rose significantly, and went on to reach similar levels to those observed
during metaphase I (6 h post release). In contrast, securin levels failed to recover and
remained at levels near those at PB1 extrusion (Fig. 3.2A, B). The securin band in the
Met II lane was not visible in the first blot (n=20), however it was observed when the
number of eggs was doubled (n=40) (Fig. 3.2C). Also, endogenous securin was lost
upon activation of eggs using Sr
2+-containing medium, which mimics the sperm-triggered
Ca
2+ release (Fig. 3.2C).94
Fig. 3.1. Exogenous cyclin B1 and securin synthesis rates during meiotic maturation.
Cyclin B1-YFP (A) or securin-YFP (B) were microinjected into GV oocytes, which were
then matured in culture. YFP fluorescence readings were recorded at the times shown
during oocyte maturation and following extrusion of the first polar body (PB1).
Brightfield images were also captured at the same times to determine when PB1
extrusion occurred (arrow). (C) Comparison of cyclin B1-YFP and securin-YFP
fluorescence levels in eggs two hours after PB1 extrusion. There was no statistical
difference between fluorescence levels (t-test). To allow comparison between eggs of
YFP fluorescence levels after PB1, fluorescence at time t (Ft) were all normalized with
respect to the minimum fluorescence obtained, which invariably corresponded to when
the PB1 was extruded (Fmin, plotted as a dashed horizontal line). YFP fluorescence was
plotted as Ft/Fmin × 100.95
Fig. 3.2. Endogenous cyclin B1 and securin expression varies after polar body
extrusion. (A) Western blot of oocytes (n = 20 per lane) for cyclin B1 and securin during
GV arrest, at the times indicated in hours during maturation relative to milrinone wash
out, immediately following PB1 extrusion or during Met II arrest at 14 h. (B)
Densitometric analysis of Western blots from three independent experiments. The results
are mean ± s. d. Cyclin B1 levels rise appreciably following PB1 extrusion, however
there is little change in securin. (C) Western blot of eggs for securin (n = 40) with or
without incubation in Sr
2+ containing medium for 3 h. In panels A and C actin was used
as a loading control.96
3.2.3. CDK1 inhibition does not induce sister chromatid separation
During the Met II arrest, low securin and high cyclin B1 levels suggest that at this stage
separase could be either inhibited by CDK1/cyclin B1, or by the low levels of securin.
To further investigate this, I decided to disturb CDK1 activity in the Met II-arrested eggs
using the CDK1 pharmacological inhibitor, roscovitine. This inhibitor was chosen
because it was previously reported to be able to induce egg activation and PB2 extrusion
(Gorr et al., 2006; Phillips et al., 2002). In agreement with this, within half an hour of
exposure to roscovitine, the eggs started to demonstrate signs of parthenogenetic
activation through PB2 extrusion, although this happened at lower rates and in some eggs
over a longer timeframe than Sr
2+-treated eggs (Fig. 3.3A, B). Many of the roscovitine-
treated eggs attempted to extrude PB2, however the extrusion was transitory and the polar
body ended up being reabsorbed (Fig. 3.3C). Unexpectedly, in addition to the transitory
polar bodies, when the chromatin of the roscovitine-treated eggs was labelled with
Hoechst dye, I found that sister disjunction was aberrant. In some eggs all the chromatin
mis-segregated into the PB2 (Fig. 3.3D), in others it ended up stretched between the egg
and PB2 (Fig. 3.3E). The Hoechst real time observations were further confirmed by
chromosome spreads, which showed that sister chromatids remained attached in the
roscovitine-activated eggs (Fig. 3.3F). On the other hand, in the control Sr
2+-activated
eggs, anaphase was readily observed and it was always coupled with equal segregation of
the chromatin between the egg and PB2 (Fig. 3.3G).97
Fig. 3.3. CDK1 inhibition does not induce sister chromatid separation. (A) Rates of
PB2 extrusion in Met II eggs following incubation in Sr
2+ containing medium, or addition
of roscovitine; assessed at 7 h. (B) Timing of PB2 extrusion following addition of
roscovitine or Sr
2+, plotted as a cumulative percent of the total number of eggs extruding98
a PB2. Some eggs were slower in extruding a PB2 following roscovitine addition than
Sr
2+. (C-E) Brightfield and Hoechst images of eggs following addition of roscovitine at
the times indicated. Note the abnormal events associated with roscovitine addition: a
transitory extrusion of a polar body (C), an egg in which all the chromatin enters the
polar body (D, circle); a cut phenotype in which chromatin is stretched between the egg
and PB2 (E, arrow). (F) Chromosome spread of a roscovitine treated egg showing
attached sister chromatids (n = 25). (G) Brightfield and Hoechst images of eggs
following Sr
2+ addition at the times indicated. Note that anaphase appears normal with
chromatin visible in both the PB2 and the egg (arrow).  Scale bars 20 μm (C-E, G); 
10 μm (F). 99
3.2.4 Inhibition of separase-CDK1 binding fails to induce sister chromatid
separation
Inhibition of CDK1 led to parthenogenetic stimulation of eggs but it could not induce
sister chromatid separation, suggesting that during Met II arrest, MPF activity is not
responsible for inhibiting separase. To further confirm this, I decided to use a more
specific approach, an antibody that blocks the interaction of MPF with separase (Gorr et
al., 2006; Phillips et al., 2002). This antibody, called anti-CBD antibody, was raised
against the two known cyclin B1-biniding determinants of mouse separase (amino acids
1120-1134 and 1340-1354). Injection of the anti-CBD antibody into eggs did not disrupt
the Met II arrest, as assessed by Hoechst staining, and failed to induce sister chromatid
separation, as judged by chromosome spreads (Fig. 3.4A, B). However, it remained
possible that the anti-CBD antibody is only effective at preventing the interaction
between MPF and separase prior to their mutual binding. To verify that this antibody is
indded capable of dissolving the separase/MPF complex, I decided to inhibit homologue
disjunction by injecting the cRNA for the non-degradable 90 cyclin B1 into GV
oocytes, which were then allowed to mature in culture. These oocytes went as far as Met
I and then arrested again with paired homologues, as reported previously (Herbert et al.,
2003). Interestingly, injection of the anti-CBD antibody, but not control IgG, induced
homologue disjunction, as assessed by chromosome spreads (Fig. 3.4C, D). However, no
PB1 was extruded, and this is attributed to the high MPF activity, which is unaffected by
the antibody (Gorr et al., 2006). These results are consistent with the ability of the anti-
CBD antibody to dissolve preformed MPF-separase complexes.100
Taken together, both the roscovitine and the anti-CBD antibody data demonstrate that
MPF is not responsible for inhibiting separase activity during Met II arrest.
3.2.5 Securin Knockdown induces sister chromatid separation
Having shown that MPF is not the inhibitor responsible for regulating separase during the
Met II arrest in mouse eggs, I went on to investigate whether it is the low levels of
securin that inhibit separase activity. Therefore, I performed knockdown of securin
expression in oocytes using a securin antisense morpholino (securin
MO). Microinjection
of securin
MO in GV oocytes, which were then kept arrested for 24 h, dramatically reduced
securin levels. The control 5 base mismatch securin morpholino (5MM-securin
MO),
however, had no effect (Fig. 3.5A). GV oocytes that were depleted of securin by this
protocol, alongside control morpholino-injected oocytes, were cultured for 14 h and then
assessed for their abilities to extrude PB1 and to align chromatin on Met II spindle.
There was no difference between both groups in the ability to extrude PB1 (Fig. 3.5B).
However, when the chromatin of the securin
MO-injected eggs was examined using
Hoechst staining, I noticed that it was dispersed throughout the cytoplasm. In contrast,
the chromatin was perfectly aligned on the Met II plate in the 5MM-securin
MO injected
oocytes (Fig. 3.5B, C). To determine if the status of chromatin observed in the securin-
knocked down oocytes was due to a lack in sister chromatid pairing, chromosome spreads
were performed. In the control morpholino-injected oocytes, the sister chromatids were
perfectly attached, as assessed by Giemsa staining and C-banding (Fig. 3.5D).101
Fig. 3.4. Inhibition of separase–CDK1 binding fails to induce sister chromatid
separation. (A) Assessment of Met II status in eggs injected with anti-CBD antibody, as
judged by alignment of chromatin on a Met II plate (arrow). The antibody had little effect
on chromatin. (B) Chromosome spread of an anti-CBD antibody injected egg (n = 6) at
3 h after injection showing attached sister chromatids (one chromatid is magnified in
inset). (C, D) Chromosome spread of an oocyte arrested at Met I by injection of Δ90-
cyclin B1, which is then further injected with either control IgG (C, n = 7) or anti-CBD
antibody (D, n = 8) and incubated for 3 h. IgG injection had no effect on homologues,
which remain attached; however the anti-CBD antibody caused separation of
homologues. (Insets show a magnified bivalent or dyad). Scale bar 20 μm (A), or 10 μm 
(B–D).102
Unexpectedly, spreads performed on the securin
MO-injected oocytes showed that
although homologues and sister chromatids were attached before PB1 (Fig. 3.5E),
following PB1 extrusion sister chromatids were separated, which was further confirmed
by C-banding (Fig. 3.5F).
To certify that the lack in sisters pairing, which occurs as a result of securin knockdown,
was not due to an off-target effect, I decided to rescue the phenotype by injecting securin
cRNA into securin
MO-injected oocytes, just before their release. This rescue is made
possible by the fact that exogenous cRNA lacks the 5’ UTR that is targeted by the
morpholino. Spreads performed on these oocytes showed that securin cRNA rescued the
loss of sister attachment in securin
MO-injected oocytes, and this was further confirmed by
C-banding (Fig. 3.5G).
3.2.6 Securin knockdown during Met II arrest induces sister chromatid separation
The above data show that securin knockdown induces sister chromatid separation in
oocytes that had extruded PB1, but not in those yet to extrude PB1. To ensure that sister
chromatid disjunction happens during meiosis II, I performed knockdown of securin
expression in eggs already arrested at Met II. Therefore, freshly ovulated Met II eggs
were collected at 12 h post hCG, microinjected with either 5MM-securin
MO or securin
MO
and examined 12h later for attachment of sister chromatids. Western blots confirmed that
12 h of culture following securin
MO injection was enough to cause a dramatic decrease in
securin levels, whereas the 5MM- securin
MO had no effect (Fig. 3.6A).103
Fig. 3.5. Securin knockdown induces separation of sister chromatids. (A) Western
blot for securin in GV arrested oocytes, n = 0–50 per lane, cultured for 24 h following
injection of securin
MO or 5MM-securin
MO as indicated (n = 3). Securin
MO but not its 5
base mismatch control morpholino caused a large knockdown in securin expression
(estimated 80%). (B) Percentage PB1 extrusion rates in oocytes injected with either
securin
MO or 5MM-securin
MO as in panel A, assessed at 14 h following milrinone
washout. All eggs extruding a PB1 were stained with Hoechst and categorised as having
an intact Met II spindle (solid bar) or chromatin that was dispersed in the cytoplasm
(open bar). (C) An example of a brightfield and Hoechst image in an egg that had been
injected with the morpholinos indicated and matured as in panel B. The arrow shows a
normal Met II plate which was prevalent in the 5MM-securin
MO injected oocytes, while
chromatin is dispersed in the oocytes injected with securin
MO. (D–G) Chromosome
spreads and associated C-banding (D, F, and G, inset) in oocytes at either 7 h (E) or 14 h
(D, F and G) following microinjection of either 5MM-securin
MO (D) or securin
MO (E-G).
In panel G securin cRNA was further microinjected into oocytes immediately before
maturation was induced. Scale bar 20 μm (C) and 10 μm (D–G).  104
Chromosome spreads performed on these eggs revealed that most (86%) of the control
morpholino injected eggs kept their sister chromatids attached (Fig. 3.6B, C), whereas
the majority (71%) of securin
MO-treated eggs showed a mixture of attached and
unattached sisters, with complete disjunction evident in some eggs (Fig. 3.6B, D).
Finally, to confirm that securin knockdown using morpholino does not affect MPF
activity and that sister chromatid disjunction is only caused by the loss of securin, I
performed H1 kinase assay on securin
MO-injected eggs, along with control morpholino-
injected, non-injected and roscovitine or Sr
2+-treated eggs. Both roscovitine and Sr
2+
induced a big decrease in the H1 kinase activity of the treated eggs. However, there was
no difference between the non-injected and the morpholinos-injected eggs in their H1
kinase activity, suggesting that securin
MOdoes not affect MPF activity (Fig. 3.6E). Taken
together, these results demonstrate that only securin and not MPF is required for
continued attachment of sister chromatids during Met II arrest in mouse eggs.
3.3 Discussion
In vertebrates, it is well established that separase is controlled by two mechanisms,
securin and MPF (Ciosk et al., 1998; Petronczki et al., 2003; Zou et al., 1999). These two
inhibitory systems are mutually exclusive at the molecular level, such that if one goes
missing the other one can compensate for it (Gorr et al., 2005; Herbert et al., 2003).105
Fig. 3.6. Securin morpholino induces sister chromatid separation in Met II eggs. (A)
Western blot for securin in Met II eggs, n=40 per lane, cultured for 12 h following
collection or injection with either securin
MO or 5MM-securin
MO. Securin
MO but not its
control morpholino caused a large knockdown in securin expression. Actin was used as a
loading control. (B) Percentage of eggs having separated (black bars) or attached (white
bars) sister chromatids following microinjection of either 5MM-securin
MO or securin
MO
and culture for 12 h. (C) Chromosome spread of a 5MM-securin
MO injected egg,
demonstrating attached sisters. (D) Chromosome spread of a securin
MO injected egg in
which all of the sister chromatids had undergone disjunction. (E) MPF activity in 5 eggs
per lane, following injection with 5MM-securin
MO, securin
MO, no injections (no inj.) and
incubation with either roscovitine or Sr
2+. MPF activity was assessed after 12 h of
culture, and normalized with respect to the non-injected eggs. Scale bar 10 m (C, D).106
This mutuality has been proven in many systems including eggs, where we already know,
by over expression of non-degradable constructs for either cyclin B1 or securin, either
mechanism has the capacity to prevent sister chromatid separation upon egg activation
(Madgwick et al., 2004). These observations, although important in implicating separase
in sister chromatid disjunction, fail to give any context to the relative contribution of
securin and cyclin B1 to the inhibition of separase during Met II arrest in eggs, especially
that sister chromatid separation eventually occurs at later stages in the non-degradable
cyclin B1-injected eggs (Madgwick et al., 2004).
The experiments described in this study show that even though endogenous and
exogenous securin and cyclin B1 display similar profiles of expression during meiosis I,
very marked differences were observed following PB1 extrusion. While the exogenous
constructs show equal re-accumulation and stability during Met II arrest, the endogenous
securin failed to recover and remained at levels near those at PB1 extrusion. This failure
in securin recovery can only be attributed to the limited rates of the protein re-synthesis
rather than degradation, given that Emi2 inhibits the activity of the APC/C at this time
(Liu and Maller, 2005; Rauh et al., 2005; Shoji et al., 2006; Tung et al., 2005).
The lack of appreciable securin re-accumulation after PB1 extrusion suggests that
CDK1/cyclin B1 could be the predominant inhibitor of separase during Met II arrest.
Interestingly, preventing the interaction of CDK1/cyclin B1 with separase,107
pharmacologically using the CDK1 inhibitor roscovitine or directly by injection of an
anti-CBD antibody, failed to induce separase activation and sister chromatid separation.
Roscovitine was specifically chosen because of its reported ability to induce PB2
extrusion (Phillips et al., 2002). Indeed, addition of roscovitine induced egg activation
and PB2 extrusion, although the metaphase-to-anaphase transition was always abnormal.
In many of the roscovitine-treated eggs PB2 extrusion was transitory, indicating that
roscovitine is able to induce higher rates of PB2 extrusion than those reported in Fig.
3.3A, but they were missed because of the transitory effect. The same phenotype was
reported during meiosis I in mouse oocytes expressing non-degradable securin (Herbert
et al., 2003), and it is believed that the inability of those oocytes to completely extrude
polar bodies is due to failure in formation of a central spindle structure, which is
necessary for proper cytokinesis (Mollinari et al., 2005). Although the decrease in CDK1
activity was clearly inducing the initial events of cytokinesis, it failed to induce sister
chromatid separation. Instead, I observed a variety of defects all associated with lack of
sister disjunction. In some eggs all the chromatin mis-segregated to the PB2. In others it
ended up stretched between the egg and PB2, which is reminiscent of the cut phenotype
that happens when cells carrying a mutant form of separase or expressing non-degradable
securin fail to induce separation of sister chromatids even though they undergo
cytokinesis (Funabiki et al., 1996). Failure of roscovitine in inducing sisters disjunction
could be attributed to the fact that this pharmacological inhibitor, while it inhibits CDK1
activity, it is unable to dissolve the pre-formed CDK1/cyclin B1-separase complexes.
However, given that CDK1-mediated phosphorylation of separase is required prior to108
CDK1 binding, and separase dephosphorylation is readily observed during passage
through mitosis (Herbert et al., 2003; Stemmann et al., 2001), I assume that roscovitine
should be able to reverse the association of CDK1 with separase, at least in the presence
of the cellular phosphatases.
The lack of efficacy for CDK1 in inhibiting separase during Met II arrest was further
confirmed using a more specific approach, the anti-CBD antibody, which prevents the
interaction of CDK1/cyclin B1 with separase (Gorr et al., 2006). Injection of the
antibody into eggs had no effect on neither metaphase II arrest nor sister chromatid
attachment. In contrast, the anti-CBD antibody induced homologue disjunction in Met I-
arrested  oocytes  that  were  pre-injected  with  the  non-degradable  Δ90  cyclin  B1, 
confirming its ability to dissolve the pre-formed MPF-separase complexes. Interestingly,
even though the antibody was able to cause homologue segregation in these oocytes, it
was unable to induce cytokinesis and PB1 extrusion. This can only be attributed to the
sustained MPF activity, which is unaffected or even increased in the presence of the
antibody, given that MPF binding to separase was proven to induce inhibition of both
kinase and protease (Gorr et al., 2005). Taken together all these data confirm that MPF is
not required for the continued attachment of sister chromatids during Met II arrest.
In contrast, a securin antisense morpholino injected either into GV oocytes, which were
then allowed to mature, or into Met II-arrested eggs, induced sister chromatid separation.
This effect was specific since it was not observed with the control morpholino, and could
be rescued by injection of securin cRNA into the securin
MO-treated ooytes. Interestingly,109
securin knockdown only induced chromosomes separation following PB1 extrusion and
not during meiosis I. This suggests that securin is the predominant inhibitor of separase
during Met II arrest, whereas during meiosis I a second mechanism that is securin-
independent is involved in regulating separase activity. Indeed, it was reported that
during the first meiotic division separase is regulated by both securin and MPF, and loss
of both systems is required for separase activation and homologue disjunction (Herbert et
al., 2003).
Also, a recent study by Marangos and Carroll (2008) reported the existence of
competitivity between the APC/C substrates, such that excess in securin levels is
important for the stabilization of cyclin B1 and hence progress through MI (Marangos
and Carroll, 2008). So, it remained possible that sister chromatid disjunction, which has
occured upon securin knockdown, was also attributed to a drop in MPF activity as a
result of cyclin B1 targeted destruction by the APC/C in the absence of securin.
However, this was unlikely since there was no difference in MPF activity of either
securin
MO or 5MM-securin
MO injected eggs, which further proves that only securin is
required for separase inhibition and continued attachment of sister chromatids during Met
II arrest in mouse eggs.
In conclusion, this study demonstrates that although there are conditions in which either
securin or MPF can prevent chromosome disjunction, such as during meiosis I, securin is
the predominant inhibitor of separase during the indeterminate period of Met II arrest.
The low levels of securin during meiosis II were proven to be sufficient for regulating110
separase activity, therefore it would be interesting to investigate what other functions
securin might have during meiosis I, given that its levels at this stage were much higher
than those observed during Met II arrest. It will also be worth to examine if the
maintenance of securin levels present problems for ageing eggs in keeping sister
chromatids attachment. Moreover, it would be interesting to investigate the mechanisms
behind separase regulation in eggs from securin knockout mice, given that securin
inactivation was only found to cause sub-fertility in those mice (Wang et al., 2001). It
would also be crucial to further confirm the results obtained in this chapter using
additional securin morpholinos and CDK1 inhibitors.111
Chapter 4: MPF and MAPK are required for inhibiting
premature destruction of securin during prometaphase of
meiosis I.
4.1 Introduction
As already mentioned in previous chapters, securin is the best-known regulator of the
protease separase. It is a functionally conserved protein, although there is little
conservation of its primary amino acid sequence, except for the presence of D-box and
KEN-box motifs. Hence, allowing its targeted destruction by the APC/C at the
metaphase-to-anaphase transition, which in turn triggers chromosomes separation
through activation of separase (Ciosk et al., 1998; CohenFix et al., 1996; Funabiki et al.,
1996; Uhlmann, 2001).
Securin was originally identified in budding yeast as Pds1, which is important but not
essential for sister chromatid disjunction (Ciosk et al., 1998; CohenFix et al., 1996). Its
depletion does not cause lethality but results in precocious separation of sister chromatids
and increased rates of chromosome loss (Yamamoto et al., 1996). In contrast, securin of
fission yeast (Cut2) and Drosophila (PIM) are essential (Funabiki et al., 1996a; Funabiki
et al., 1996b; Leismann et al., 2000; Stratmann and Lehner, 1996). Their absence leads
to impairment in separase activity and failure in separating sister chromatids, suggesting
that Cut2 and PIM must be more than simple inhibitors of separase (Funabiki et al.,
1996b; Jensen et al., 2001; Leismann et al., 2000). Indeed, fission yeast securin, for
example, was proven to be required in promoting spindle localization of separase
(Kumada et al., 1998). In Drosophila and fission yeast, non-degradable PIM and Cut2112
cause the cut phenotype (Funabiki et al., 1996b; Leismann et al., 2000), whereas budding
yeast with non-degradable Pds1 arrests in M phase (Clarke et al., 1999; Gardner et al.,
1999).
Vertebrate securin was first described as the product of the pituitary tumour-transforming
gene (PTTG), which is over-expressed in several neoplasms, including the pituitary ones
(Pei and Melmed, 1997). It has subsequently been identified as securin due to its ability
to bind and regulate separase (Leismann et al., 2000; Zou et al., 1999). The oncogenic
nature of PTTG over-expression is believed to be caused by defective sister chromatid
separation, resulting in aneuploidy, which is one of the main criteria in tumour
development. Accordingly, it was demonstrated that human cell lines expressing non-
degradable PTTG exhibit the cut phenotype (Zur and Brandeis, 2001), whereas those
lacking PTTG show high chromosome loss and abnormal anaphases (Jallepalli et al.,
2001). Also, PTTG knockout mice, although they are viable, the females are sub-fertile
and their embryonic fibroblasts display aberrant chromosome morphology, aneuploidy
and prolonged G2 and M phases (Mei et al., 2001; Wang et al., 2001).
The crucial role of securin in preventing premature activation of separase and
maintaining chromosome attachment until anaphase onset, suggests that it must be highly
regulated by mechanisms responding to cell cycle progression. Indeed, in addition to
being expressed in a cell-cycle-dependent manner, peaking in M phase and getting
destroyed at anaphase onset (Nabti et al., 2008; Ramos-Morales et al., 2000), during the
course of this study it has been reported that securin is subject to another layer of113
regulation, phosphorylation. This was demonstrated by Holt et al (2008), who found that
MPF-dependent phosphorylation of securin near its D-box motif reduces its rate of
ubiquitination by the APC/C in budding yeast (Holt et al., 2008). Securin
phosphorylation, however, can be reversed by the phosphatase Cdc14, whose activation
requires separase activity (Holt et al., 2008). Therefore, at anaphase onset and due to
accumulation of APC/C activity, some securin is destroyed, leading to activation of
separase. This in turn results in Cdc14 activation, more securin being targeted for
degradation and more separase getting active (Holt et al., 2008). Accordingly, these
findings suggest the existence of a positive feedback loop that makes separase activation
more switch-like, therefore increasing the abruptness of anaphase and sister chromatid
separation (Holt et al., 2008). It also has been suggested in other studies that securin
interacts with and is a substrate of MAPK (Pei, 2000), although the significance of such
interaction on securin stability and function as a separase regulator is still unknown.
I found here that inhibition of both MPF and MAPK, but not either one alone, induces
premature destruction of securin during prometaphase of meiosis I. Also, securin
stability could be rescued through inhibition of the proteasome or cellular phosphatases.
However, mutations of the three candidate phosphorylation sites of MPF and MAPK had
no effect on securin stability. Therefore, MPF and MAPK-mediated stability of securin
during prometaphase I could not be brought about through its phosphorylation and may
be mediated via an indirect mechanism.114
4.2. Results
4.2.1. Securin undergoes a gel-mobility shift at the GV to MI transition.
In somatic cells, it was reported that securin is phosphorylated upon entry into the M-
phase (Ramos-Morales et al., 2000). At the exit from prophase arrest and upon entry into
meiosis I, mouse securin also undergoes a gel-mobility shift, which is suggestive of
phosphorylation (Fig. 4.1). This shift was noted in numerous earlier studies but has not
yet been investigated (Marangos and Carroll, 2008; Nabti et al., 2008).
4.2.2. Inhibition of both MPF and MAPK induces premature destruction of
endogenous securin.
The transition from prophase arrest to MI is driven by an increase in CDK1/cyclin B1
activity. After GVBD, there is also an increase in MAPK activity. Therefore, to
determine whether the observed mobility shift of securin at the GV to MI transition was
indeed caused by phosphorylation and if this is catalysed by CDK1 and MAPK, the
activity of both kinases was inhibited using the pharmacological inhibitors, roscovitine
and UO126, respectively. The oocytes were exposed to the drugs between 3-5 h after
release from GV arrest. Western blots performed on these oocytes demonstrated that
inhibition of both CDK1 and MAPK results in a loss of the band shift (Fig. 4.2.A), as
well as a decrease in the levels of securin (Fig. 4.2A, B, C). However, inhibition of
either kinase alone did not affect securin levels, which remained as high as those
observed in the non-treated MI oocytes (Fig. 4.2.B, C).115
Fig. 4.1. Securin undergoes a gel-mobility shift at the GV to MI transition. Western
blot of oocytes (n=20 per lane) for securin during GV arrest and MI (at 5 h post release
from IBMX). This blot is representative of three independent experiments.116
These results indicate that the band shift observed at the GV to MI transition could be
due to securin phosphorylation, and suggest that this might be catalysed by CDK1 and
MAPK. Furthermore, CDK1 and MAPK activities seem to be required for accumulation
of securin during prometaphase I.
4.2.3. Inhibition of both MPF and MAPK induces premature destruction of
exogenous securin.
Simultaneous inhibition of CDK1 and MAPK induced a decrease in the levels of
endogenous securin. To further investigate this, I performed timelapse fluorescence
measurements of oocytes injected with the cRNA construct for green fluorescent protein
(GFP) tagged securin (securin-GFP) during maturation in the presence or absence of
roscovitine and UO126. The measurements demonstrated that in the inhibitors-treated
oocytes, securin destruction occurs prematurely (at around 3 h post GVBD) (Fig. 4.3.A,
C), whereas in the control non-treated oocytes, securin degradation starts much later (at 7
h post GVBD) (Fig. 4.3.B, C). Taken together, these results further confirm that CDK1
and MAPK activities are required for securin stability during prometaphase of meiosis I.
4.2.4. Proteasome and phosphatase inhibitors restore securin levels.
Next, it was important to examine whether the observed decrease in securin levels
required the 26S proteasome. Therefore, the oocytes were further incubated with the
proteasome inhibitor (MG132).117
Fig. 4.2. Inhibition of MPF and MAPK induces premature destruction of
endogenous securin. (A) Western blot of oocytes (n=20 per lane) for securin during GV
arrest, MI, and MI following incubation with roscovitine and UO126 (MI+R+U). (B)
Western blot of oocytes (n=20 per lane) for securin during GV arrest, MI, and MI
following treatment with either roscovitine (R), UO126 (U) or both roscovitine and
UO126 (R+U). (C) Densitometric analysis of the Western blot in panel B. The results
are mean ± s. d. from three independent experiments. MI is set at 100%. The asterisks
represent a value significantly different from control (the MI value) at
**P (0.001-0.01).
In panels A and B, all MI samples were collected at 5 h post release from IBMX, and
drug treatment was performed between 3 and 5h. Actin was used as a loading control.118
Fig. 4.3. Inhibition of MPF and MAPK induces premature destruction of securin-
GFP. Representative traces of oocytes injected with securin-GFP. The oocytes were
injected at the GV stage and then matured in culture in the presence (A) or absence (B) of
roscovitine and UO126 (R+U). The fluorescence readings were recorded at the times
shown during oocyte maturation. In panel A, the drugs were added at 1 h post GVBD
(red arrow). (C) Time of onset of securin-GFP destruction in the inhibitors-treated
oocytes (R+U) and non-treated oocytes (control). The peak of the graph was taken as a
marker for the start of destruction. The results are mean ± s. d. from three independent
experiments. The asterisks represent a value significantly different from control at
**P
(0.001-0.01).119
Western blot performed on these oocytes showed that MG132 restores securin levels to
the MI levels, suggesting that the decrease in securin levels upon CDK1 and MAPK
inhibition is due to 26S proteasome-mediated destruction (Fig. 4.4.A, B). Moreover, the
protein phosphatase 1 and 2A inhibitor (okadaic acid) also rescued securin levels (Fig.
4.4.A, B), and oocytes incubated with the phosphatase inhibitor were less efficient at
destroying securin-GFP at the metaphase-to-anaphase transition when compared to
oocytes in control conditions (Fig. 4.4.C), which suggest that securin stability during
meiosis I may depend on its phosphorylation status.
4.2.5. Prometaphase I securin stability does not depend on the phosphorylation
status of the three MPF and MAPK sites.
Having shown in the previous experiment that okadaic acid treatment prevents the
premature destruction of securin when CDK1 and MAPK are inhibited, I went on to
investigate whether the possible phosphorylation of securin by those two kinases
increases its stability. Examination of the amino acid sequence for mouse securin using
the Scansite program (http://scansite.mit.edu) showed six consenus motifs for MPF
phosphorylation and five for MAPK phosphorylation. However, since securin stability
requires the activity of either MPF or MAPK, only the sites that can be phosphorylated
by either kinase were chosen for mutagenesis (Fig. 4.5.A). Therefore, I created a Phos
-
mutant of securin in which the three-shared sites (T43, S165 and S171) were substituted
for alanine residues, thus preventing them from becoming phosphorylated.120
Fig. 4.4. Proteasome and phosphatase inhibitors restore securin levels. (A) Western
blot of oocytes (n=20 per lane) for securin during GV arrest, MI, MI following
incubation with roscovitine and UO126 (R+U), and MI after treatment with either
MG132 or okadaic acid (OA) in addition to roscovitine and UO126. All MI oocytes were
collected at 5 h post release from IBMX, and drug treatment was performed between 3
and 5 h. Actin was used as a loading control. (B) Densitometric analysis of Western
blots from three independent experiments. The results are mean ± s. d. MI is set at
100%. The asterisks represent a value significantly different from control (the MI value)
at
**P (0.001-0.01). (C) Representative traces of oocytes (from two independent
experiments) injected with securin-GFP at the times shown during maturation, in the
presence (n=10, red) or absence (n=10, black) of okadaic acid. The arrow indicates time
of okadaic acid addition.121
Timelapse fluorescence records of oocytes injected with cRNA constructs for GFP
tagged Phos
- securin (Phos
- securin-GFP) or wild type securin (securin-GFP)
demonstrated similar expression profiles and stability during oocyte maturation (Fig.
4.5.B). However, since these measurements represent the balance between protein
synthesis and destruction, it remained possible that the changes in destruction are masked
by the rates of synthesis. To exclusively monitor protein destruction, the oocytes were
incubated in the presence of cycloheximide to inhibit protein synthesis while monitoring
the levels of securin-GFP. This also failed to reveal any difference in the behaviour of
the non-phosphorylable mutant and wild type securin during prometaphase I (Fig. 4.5.C).
These data suggest that in mouse oocytes, the phosphorylation of securin at the three
MPF and MAPK sites may not underlie the changes in its stability when MPF and
MAPK are inhibited.
4.2.6. Phos
- mutations do not affect securin function.
Next, I wanted to investigate whether the Phos
- mutations had any effects on securin
function. In the previous chapter, I have shown that securin is the main inhibitor of
separase during Met II arrest, and that securin morpholino knockdown during this period
resulted in chromatin misalignment, due to sister chromatid separation. However, this
phenotype could be rescued by injection of securin cRNA in the morpholino-treated eggs.
Therefore, to test whether the non-phosphorylable securin mutant was also capable of
rescuing this phenotype, Met II-arrested eggs were co-injected with securin
MO and the
cRNA for either Phos
- or wild type securin. The eggs were then assessed for their
chromatin status by Hoechst staining 12 h following the microinjections.122
Fig. 4.5. The phosphorylation status of securin at the three MPF and MAPK sites
has no affect on its stability during prometaphase I. (A) A schematic diagram of
mouse securin showing the relative position of CDK1 and MAPK phosphorylation sites
to the APC recognition motifs and the separase inhibition domain. (B) Representative
traces of oocytes (from two independent experiments) injected with either Phos
- securin-
GFP (n=15) or wild type securin-GFP (n=13) at the times shown during maturation. (C)
Representative traces of oocytes (from two independent experiments) injected with either
Phos
- securin-GFP (n=12) or wild type securin-GFP (n=12) at the times shown during
maturation, in the presence of cycloheximide (CHX).123
As reported previously, the chromatin in the morpholino-treated eggs was misaligned and
this phenotype could be rescued by injection of wild type securin (Fig. 4.6.A, B). More
importantly, injection of the Phos
- securin mutant in the securin
MO-treated eggs also
rescued sister chromatid attachment, as judged by the proper alignment of the chromatin
(Fig. 4.6.A, B). Taken together, these results suggest that securin phosphorylation at the
three MPF and MAPK sites was not critical for its function as a separase inhibitor.
4.3. Discussion
It is well established that securin plays a crucial role in ensuring the faithful segregation
of chromosomes through regulating the activity of the protease separase. For that reason,
securin is highly regulated by mechanisms responding to cell cycle progression. In
mitosis, as well as meiosis, this is mainly achieved through the control of its expression,
which is done in a cell-cycle-dependent manner, with securin peaking in M-phase and
getting destroyed at anaphase onset (Nabti et al., 2008; Ramos-Morales et al., 2000),
therefore allowing separase activation and chromosomes separation (Ciosk et al., 1998;
CohenFix et al., 1996; Funabiki et al., 1996b; Uhlmann, 2001). Recently, however, and
during the course of this investigation it was reported by Holt et al (2008) that
phosphorylation could provide an additional layer of regulation. According to this study,
MPF-dependent phosphorylation of securin near its D-box motif reduces its rate of
ubiquitination by the APC/C in budding yeast (Holt et al., 2008). More importantly, this
additional regulatory mechanism seems to be conserved, as it was also observed in
human PTTG and Drosophila PIM (Holt et al., 2008).124
Fig. 4.6. Phos
- mutations do not affect securin function. (A) Percentage of eggs with
dispersed (white bars) or perfectly aligned chromatin (black bars) following
microinjection of securin
MO alone, securin
MO and the cRNA for either Phos(-) or WT
securin, or no injections (no inj.). The eggs were assessed for their chromatin status by
Hoechst staining at 12 h following microinjections. (B) Representative images of the
eggs described in panel A.125
In previous experiments, it was noted that upon entry into meiosis I, mouse securin
undergoes a gel-mobility shift, which is suggestive of phosphorylation (Marangos and
Carroll, 2008; Nabti et al., 2008). To test this hypothesis, the two major M-phase
kinases, CDK1 and MAPK were inhibited using the pharmacological inhibitors,
roscovitine and UO126, respectively. The inhibition of both kinases induced a loss of the
band shift, which suggests that the mobility-shift observed at the GV to MI transition
could be due to securin phosphorylation, and suggests that this might be catalysed by
CDK1 and MAPK. Interestingly, inhibition of both kinases, but not either one alone, also
induced a decrease in the levels of endogenous securin and premature destruction of
exogenous securin during prometaphase I, indicating that the activity of either CDK1 or
MAPK might be required for the accumulation of securin during meiosis I.
The decrease in securin levels upon inhibition of both kinases was proven to be caused by
its destruction rather than inhibition of synthesis, given that the proteasome inhibitor
MG132 restored the levels of securin. More importantly, the phosphatase inhibitor,
okadaic acid, also prevented the premature degradation of endogenous securin during
prometaphase I, and stabilised the levels of exogenous securin at the metaphase-to-
anaphase transition. These findings imply that okadaic acid protects securin when CDK1
and MAPK are inhibited. There are a number of possible explanations for such effect.
First, securin destruction may be dependent on the phosphorylation of one of the
components of the degradation machinery. Alternatively, it may be that the
phosphorylation of securin results in increased stability, as reported by Holt et al 2008.126
To further investigate the latter hypothesis, the three candidate sites for MPF and MAPK
phosphorylation were substituted for alanine residues, thus preventing them from
becoming phosphorylated. Two of the sites (S165 and S171) are situated within the
separase inhibition domain, whereas the third site (T43) is near the D-box motif. Securin
mutants carrying single alanine substitutions at the three sites individually were as stable
as the wild type securin (results not shown). Also, the triple alanine securin mutant failed
to reveal any difference in its behaviour when compared to the wild type securin. These
results are not consistent with the study by Holt et al, who found that securin
phosphorylation near its D-box motif reduces its rate of ubiquitination by the APC/C,
hence promoting its stability (Holt et al., 2008). Therefore, in contrast to budding yeast,
human and Drosophila, in mouse oocytes securin phosphorylation and in particular at the
three MPF and MAPK sites may not underlie the changes in its stability.
Having shown that the Phos
- mutations had no effect on securin stability, I went on
investigating whether the phosphorylation of securin upon entry into M-phase was
important for its function as a separase inhibitor. In budding yeast, it was reported that
securin phosphorylation by MPF is required for its binding to separase and promoting the
nuclear localization of the protease (Agarwal and Cohen-Fix, 2002). Moreover, it is well
established that securin interacts with separase through its carboxy (C) terminal domain,
and mutations within this domain would modulate securin ability to bind separase
(Agarwal and Cohen-Fix, 2002; Hornig et al., 2002). Therefore, it was important to
determine whether the triple alanine securin mutant, which carries two mutations in the
separase-binding domain, maintained its function as a separase inhibitor. Indeed, the127
mutant was able to rescue the chromatin misalignment in securin
MO-injected eggs,
suggesting that the phosphorylation status of securin in general and of residues S165 and
S171 in particular does not affect its function. These results, although they are not
consistent with earlier observations, they agree with a study by Boelaert et al (2004),
which demonstrated that mutagenesis of the conserved residue S165 does not influence
human PTTG stability and function, even though it affects its transforming ability
(Boelaert et al., 2004).
In summary, the experiments reported here demonstrate that although the inhibition of
MPF and MAPK induces the premature destruction of securin during prometaphase of
meiosis I, the stability of securin during this period is not dependent on the three
phosphorylation sites for MPF and MAPK, as proven by the mutagenesis experiments.
Therefore, it would be interesting to determine what causes such premature destruction of
securin in the absence of MPF and MAPK. It will be worth examining whether this
effect is due to activation of the APC/C, whose activity is well known to be modulated by
its phosphorylation status (Hershko et al., 1994; Kotani et al., 1998; Kraft et al., 2003). It
will also be important to confirm these results using additional inhibitors of MPF and
MAPK. Finally, it will be interesting to investigate the reasons behind securin
phosphorylation upon entry into meiosis I, other than regulating its stability and function
as a separase inhibitor.128
Chapter 5: MPF and MAPK are required for inhibiting
premature destruction of the APC/C D-box substrates during
prometaphase of meiosis I.
5.1. Introduction
The initiation of anaphase and exit from M phase in both mitotic and meiotic divisions
depend on the E3 ubiquitin ligase activity of the APC/C, which ubiquitinates key cell
cycle regulators, such as securin and cyclin B1. Therefore, targeting them for destruction
by the proteasome at the metaphase-to-anaphase transition (Clute and Pines, 1999;
Herbert et al., 2003; Zur and Brandeis, 2001). As a key driver of the cell cycle, the
activity of the APC/C is subject to many regulatory mechanisms, mainly through direct
binding to co-activators, which confer substrate specificity during specific periods of the
cell cycle. The best-studied co-activator proteins are Cdc20 and Cdh1 (Visintin et al.,
1997a).
In meiosis, it is well established that Cdc20, but not Cdh1, is the mediator of the meiotic
exit in eggs of species described thus far (Herbert et al., 2003; Salah and Nasmyth, 2000).
In mammals, however, Cdh1 has been shown to play a more predominant role during
prophase I (Marangos et al., 2007; Reis et al., 2006a), prometapahse I (Reis et al., 2007)
and following PB2 extrusion (Chang et al., 2004). In mouse oocytes, APC/C
Cdh1 is
required for preventing unscheduled entry into M-phase by suppressing the levels of
cyclin B1 (Marangos et al., 2007; Reis et al., 2006a). During prometaphase I, however,
APC/C
Cdh1 targets Cdc20 for destruction thereby delaying the onset of APC/C
Cdc20129
activity and the onset of anaphase, until correct assembly of the MI spindle (Reis et al.,
2007).
Because of their essential role for the activity and specificity of the APC/C, the regulation
of Cdc20 and Cdh1 is also important. During mitosis, Cdc20 is mainly regulated through
the control of its expression, which is done in a cell-cycle-dependent manner, with Cdc20
peaking in M-phase and getting destroyed in G1 (Fang et al., 1998; Prinz et al., 1998).
Another level of regulation is through association with different inhibitors, such as Emi1
and SAC proteins (Fang et al., 1998; Miller et al., 2006; Musacchio and Salmon, 2007;
Reimann et al., 2001a; Reimann et al., 2001b; Yu, 2002). Cdh1, however, while subject
to similar levels of control as APC/C
Cdc20, is also inhibited through phosphorylation by
MPF (Jaspersen et al., 1999; Zachariae et al., 1998a), as well as binding to numerous
inhibitors, including Emi1 and the nuclear transport factors Rae1 and Nup98 (Jeganathan
et al., 2006; Miller et al., 2006; Reimann et al., 2001b).
The core-subunits of the APC/C are also subject to regulatory phosphorylation during
mitosis. However, unlike Cdh1, APC/C phosphorylation by CDK1 and Plk1 is required
for its activation and association with Cdc20 (Hershko et al., 1994; Kotani et al., 1998;
Kraft et al., 2003). Accordingly, it was demonstrated that phosphatase treatment of
mitotic APC/C in vitro prevents its activity, whereas addition of CDK1 stimulates it
(Lahavbaratz et al., 1995). Moreover, Cdc20 also gets phosyphorylated upon entry into
mitosis. However, unlike the APC/C core-subunits, this CDK1 and MAPK-dependent
phosphorylation of Cdc20 is not required for the activity of the ligase, although it is
necessary for the recognition and inhibition of the co-activator by the components of the130
SAC. This was demonstrated by Chung and Chen (2003), who found that
phosphorylation deficient mutants of Xenopus Cdc20 are insensitive to the spindle
checkpoint signal and unable to associate with its components (Chung and Chen, 2003).
In meiosis, unlike mitosis, the mechanisms of APC/C regulation are as yet largely
unexplored, especially during the prolonged period of prometaphase I. In this study, I
show that inhibition of MPF and MAPK induces premature destruction of the APC/C D-
box substrates but not Ken-box substrates. This prometaphase I instability of the D-box-
containing substrates was apparently not mediated by APC/C
Cdc20 or APC/C
Cdh1, given
that Cdc20 is also targeted for destruction and morpholino-knockdown of both Cdc20 and
Cdh1 failed to rescue securin stability. Also, the inhibition of SCF
β-TrCP using the
dominant negative mutant of its F-box protein (β-TrCP) could not restore securin levels,
suggesting it could not be SCF
β-TrCP-dependent. Therefore, this effect may be attributed
to activation of another APC/C co-activator or the core APC/C, which was recently
reported of being able to directly interact with the D-box containing substrates
independently of Cdc20 and Cdh1 (Passmore et al., 2003; Yamano et al., 2004).
5.2. Results
5.2.1. Inhibition of MPF and MAPK induces premature destruction of the APC/C
D-box substrates.
In the previous chapter, I have demonstrated that inhibition of both CDK1 and MAPK
induces the premature destruction of securin during prometaphase I. To determine
whether this phenotype was specific to securin, the stability of other APC/C substrates,131
such as cyclin B1 and geminin, was investigated. Cyclin B1 and geminin were chosen
because, similar to securin, they both accumulate during the cell cycle and are targeted
for destruction at the metaphase-to-anaphase transition by the APC/C
Cdc20 in a D-box-
dependent manner. Cyclin B1 stability was examined using Western blotting, whereas
geminin was tested using timelapse fluorescence measurements, due to the lack of the
anti-geminin antibody in the lab. Interestingly, Western blots performed on MI oocytes
that were treated with roscovitine and UO126 demonstrated that cyclin B1 is also subject
to the premature degradation upon CDK1 and MAPK inhibition (Fig. 5.1.A, B).
Moreover, timelapse fluorescence measurements of oocytes injected with the cRNA
construct for GFP tagged geminin (geminin-GFP) during maturation showed that in the
control oocytes, geminin destruction starts at 6 h post GVBD; whereas in the inhibitor-
treated oocytes it starts significantly earlier, at around 3 h post GVBD (Fig. 5.1.C, D, E).
Taken together, these results suggest that in addition to the premature degradation of
securin, inhibition of CDK1 and MAPK also induces the premature destruction of other
D-box substrates of the APC/C, including cyclin B1 and geminin.
5.2.2. Inhibition of MPF and MAPK does not induce premature destruction of
Ken-box substrates.
Having shown that the APC/C D-box containing substrates (securin, cyclin B1 and
geminin) are prematurely targeted for degradation in the absence of CDK1 and MAPK
activities, it was important to address whether this was the case for PLK1 and the D-box
mutated variant of securin (securin
DM), two substrates that rely on the KEN-box for
destruction.132
Fig. 5.1. Inhibition of MPF and MAPK induces premature destruction of cyclin B1
and geminin. (A) Western blot of oocytes (n=30 per lane) for cyclin B1 at MI in the
presence or absence of roscovitine and UO126 (R+U). The oocytes were collected at 5 h
post release from IBMX, and drugs treatment was performed between 3 and 5 h. Actin
was used as a loading control. (B) Densitometric analysis of Western blots from three
independent experiments. The results are mean ± s. d. MI is set at 100%. (C)
Representative traces of oocytes (n=20, from three independent experiments) injected
with geminin-GFP at the times shown during maturation in the presence of roscovitine
and UO126. The drugs were added at 1 h post GVBD (red arrow). (D) Representative
traces of oocytes (n=17, from two independent experiments) injected with geminin-GFP
at the times shown during maturation, in the absence of the inhibitors. (E) Time of onset
of geminin-GFP destruction in the inhibitors-treated oocytes (R+U) and non-treated
oocytes (control). The peak of the graph was taken as a marker for the start of
destruction. The results are mean ± s. d. The asterisks represent values different from
controls at
**P (0.001-0.01).133
Surprisingly, Western blots performed on the inhibitor-treated and non-treated MI
oocytes showed no significant difference in the levels of PLK1 between both groups (Fig.
5.2.A, B). Next, I performed timelapse fluorescence measurements of oocytes injected
with cRNA constructs for GFP tagged wild type securin (WT securin-GFP) or securin
DM
(securin
DM-GFP) during maturation, in the presence or absence of roscovitine and
UO126. The recordings demonstrated that wild type securin was destroyed in both the
inhibitor-treated and non-treated oocytes (Fig. 5.2.C, D, E). Although, as reported in the
previous chapter, the onset of securin degradation in the treated oocytes occurs
prematurely (at 3 h post GVBD), whereas in the non-treated oocytes, securin destruction
starts 2 h later (at 5 h post GVBD) (Fig. 5.2.C, D). Interestingly, securin
DM was stable
throughout oocytes maturation and failed to be destroyed in the presence or absence of
the drugs (Fig. 5.2.C, D, E). To ensure that securin
DM stability during MI is real, the
destruction rates of both mutant and wild type securin were monitored in GV-arrested
oocytes, which were incubated in the presence of cycloheximide to inhibit protein
synthesis. Securin
DM contains a functioning Ken-box and therefore can only be targeted
for destruction by APC/C
Cdh1. Indeed, the readings demonstrated that during the GV-
arrest, when APC/C
Cdh1 is active, securin
DM is destroyed, although its destruction was
much slower than the wild type securin (Fig. 5.2.F), presumably due to the presence of a
single KEN-box rather than a KEN- and D-box. Taken together, these results further
confirm the necessity of the D-box for the APC/C
Cdc20-mediated degradation of securin at
the metaphase-to-anaphase transition, and suggest its requirement for the efficient
destruction of securin by APC/C
Cdh1. More importantly, the D-box seems to be
indispensable for the premature destruction of securin upon MPF and MAPK inhibition.134
Fig. 5.2. Inhibition of MPF and MAPK does not induce premature destruction of
PLK1 and securin
DM. (A) Western blot of oocytes (n=20 per lane) for PLK1 at MI in
the presence or absence of roscovitine and UO126 (R+U). The oocytes were collected at
5 h post release from IBMX, and drugs treatment was performed between 3 and 5 h.
Actin was used as a loading control. (B) Densitometric analysis of Western blots from
three independent experiments. The results are mean ± s. d. MI is set at 100%. (C)
Representative traces of oocytes (from three independent experiments) injected with
either WT securin-GFP (n=11) or securin
DM-GFP (n=11) at the times shown during
maturation, in the presence of roscovitine and UO126. The drugs were added at 2 h post
GVBD (red arrow). (D) Representative traces of oocytes (from two independent
experiments) injected with either WT securin-GFP (n=11) or securin
DM-GFP (n=11) at
the times shown during maturation, in the absence of the inhibitors. (E) Representative
images of the oocytes analysed in panel D at the times shown during maturation (h post
GVBD). Scale bar 20 μm.  (F) Representative traces of oocytes injected with either WT
securin-GFP (n=12) or securin
DM-GFP (n=12) at the times shown during GV-arrest, in
the presence of cycloheximide (CHX). These results are representative of two
independent experiments.135
5.2.3. Premature destruction of securin is not APC/C
Cdc20-dependent.
Inhibition of MPF and MAPK induced premature destruction of the D-box containing
substrates only and not Ken-box substrates, suggesting that APC/C
Cdc20 is likely to be the
mediator of this effect. To test this hypothesis, the levels of Cdc20 in the roscovitine and
UO126 treated MI oocytes were examined by Western blotting. Interestingly, inhibition
of both kinases also induced the premature degradation of Cdc20 (Fig. 5.3.A), which
suggests that the instability of the D-box substrates upon MPF and MAPK inhibition
could not be brought about via the activation of APC/C
Cdc20. To further investigate this,
Cdc20 morpholino (Cdc20
MO) was utilised to deplete oocytes of Cdc20. The morpholino
was injected in GV-stage oocytes, which were kept arrested for 24 h. These oocytes were
then released, cultured for 5 h in the presence of roscovitine and UO126 and assessed for
their securin levels using Western blotting. There was no significant difference in the
levels of securin between Cdc20
MO-injected and non-injected oocytes in the presence of
the inhibitors (Fig. 5.3.A, B), which provides further evidence to suggest that securin
instability upon MPF and MAPK inhibition may not be APC/C
Cdc20-dependent. Next, it
was important to to confirm the effeciency of the Cdc20 morpholino at inhibiting the
activity of APC/C
Cdc20, given that the Cdc20 blot was hard to replicate due to problems
with the antibody. This was done through testing the abilitiy of the morpholino to block
oocytes at MI, since it is well established that the APC/C
Cdc20 is the mediator of the MI
exit. Therefore, the morpholino was injected into GV-stage oocytes, which were kept
arrested for 24h, released and then assesessed for PB1 extrusion at 14 h post realease.
Indeed, all the Cdc20 morpholino-injected oocytes blocked at MI and failed to extrude
PB1, whereas 54% of the non-injected control oocytes extruded PB1 (Fig. 5.3.C), which136
suggests that the Cdc20 morpholino is efficient at inhibiting APC/C
Cdc20 activity and
further confirms the previous findings.
5.2.4. Premature destruction of securin is not APC/C
Cdh1-dependent.
Having shown that the premature degradation of the D-box containing substrates could
not be mediated by APC/C
Cdc20, the role of APC/C
Cdh1 was investigated. Firstly, the
levels of Cdh1 in roscovitine and UO126 treated MI oocytes were examined by Western
blotting. Unexpectedly, inhibition of both kinases induced a significant increase in Cdh1
levels, which were approximately twofold higher than those observed in the control MI
oocytes (Fig. 5.4.A, B). Next, it was important to determine whether the stabilisation of
Cdh1 levels upon MPF and MAPK inhibition was responsible for APC/C
Cdh1 activation
and hence the premature destruction of securin. Therefore, oocytes were depleted of
Cdh1 using Cdh1 morpholino (Cdh1
MO). The morpholino was injected into GV-stage
oocytes, which were kept arrested for 24 h. These oocytes, alongside non-injected
oocytes, were then released, cultured for 5 h in the presence of the inhibitors and assessed
for their Cdh1 and securin levels using Western blotting. The morpholino successfully
decreased Cdh1 levels to about 25% of those observed in the inhibitor-treated but non-
injected oocytes. Nevertheless, the low level of securin in the treated oocytes was not
affected by the depletion of Cdh1 (Fig. 5.4.C, D).137
Fig. 5.3. Premature destruction of securin is not APC/C
Cdc20-dependent. (A) Western
blot of oocytes (n=20 per lane) for Cdc20 and securin at MI, and MI following
incubation with roscovitine and UO126 (R+U) in the presence or absence of Cdc20
morpholino (Cdc20
MO). Oocytes were collected at 5 h post release from IBMX, and drugs
treatment was performed between 3 and 5h. Actin was used as a loading control. (B)
Densitometric analysis of Western blots from three independent experiments. The results
are mean ± s. d. MI is set at 100%. Asterisks indicate values significantly different from
control (the MI value) at
**P (0.001-0.01) and
***P < 0.001, whereas NS represents
values not significantly different at
NSP > 0.05. (C) Rates of MI arrest and PB1 extrusion
in Cdc20
MO-injected (n=33) and non-injected oocytes (n=26).138
To further confirm the efficiency of the Cdh1 morpholino at inhibiting the activity of
APC/C
Cdh1, the morpholino was injected into GV-stage oocytes, when APC/C
Cdh1 is
known to be active. These oocytes, alongside non-injected oocytes, were kept arrested
for 24 h, and then assessed for their securin levels using Western blotting. The levels of
securin in the morpholino treated oocytes were twofold higher than those observed in the
control GV oocytes, suggesting that the Cdh1 morpholino was efficient at inhibiting
APC/C
Cdh1 activity (Fig. 5.4.E, F). Taken together, these results suggest that securin
instability upon CDK1 and MAPK inhibition could not be mediated by the APC/C
Cdh1.
5.2.5. Combined morpholino-knockdown of Cdc20 and Cdh1 induces more
destruction of securin.
In the previous sections I have demonstrated that depletion of either Cdc20 or Cdh1
failed to rescue the premature destruction of securin upon CDK1 and MAPK inhibition.
Next, I decided to deplete the oocytes of both co-activators. Therefore, Cdc20 and Cdh1
morpholinos were simultaneously injected into GV-stage oocytes, which were kept
arrested for 24 h. These oocytes, alongside non-injected oocytes, were then released,
cultured for 5 h in the presence or absence of roscovitine and UO126 and assessed for
their securin levels using Western blotting. Unexpectedly, simultaneous knockdown of
Cdc20 and Cdh1 induced an increased destruction of securin, whose levels were
significantly lower than those observed in the non-injected oocytes, in the presence or
absence of the inhibitors (Fig. 5.5.A, B). These data raise the possibility that neither
APC/C
Cdc20 nor APC/C
Cdh1 mediates the premature destruction of securin upon MPF and
MAPK inhibition, and that additional factors may be acting.139
Fig. 5.4. Premature destruction of securin is not APC/C
Cdh1-dependent. (A) Western
blot of oocytes (n=20 per lane) for Cdh1 at MI in the presence or absence of roscovitine
and UO126 (R+U). (B) Densitometric analysis of the Western blot in panel A. The
results are mean ± s. d. from three independent experiments. (C) Western blot of oocytes
(n=30 per lane) for securin and Cdh1 at MI, and MI following incubation with
roscovitine and UO126 (R+U), in the presence or absence of Cdh1 morpholino (Cdh1
MO). (D) Densitometric analysis of the Western blot in panel C. The results are mean ±
s. d. from three independent experiments. In panels A and C, all MI samples were
collected at 5 h post release from IBMX, and drugs treatment was performed between 3
and 5h. In panels B and D, MI is set at 100% and the asterisks indicate values
significantly different from controls (MI values) at
*P (0.01-0.05), whereas NS represents
values not significantly different at
NSP > 0.05. (E) Western blot of oocytes (n=20 per
lane) for securin and Cdh1 at the GV stage, in the presence or absence of Cdh1
morpholino. (F) Densitometric analysis of the Western blot in panel E. GV is set at
100%. Actin was used as a loading control.140
Fig. 5.5. Combined knockdown of Cdc20 and Cdh1 induces more destruction of
securin. (A) Western blot of oocytes (n=20 per lane) for securin at MI in the presence or
absence of roscovitine and UO126 (R+U), and MI following microinjection with Cdc20
and Cdh1 morpholinos in the presence or absence of the inhibitors. MI oocytes were
collected at 5 h post release from IBMX, and drugs treatment was performed between 3
and 5h. Actin was used as a loading control. (B) Densitometric analysis of Western blots
from three independent experiments. The results are mean ± s. d. MI is set at 100%.
Double and triple asterisks indicate values significantly different from control (the MI
value) at
**P (0.001-0.01) and
***P < 0.001. Single asterisk represents two significantly
different values at
*P (0.01-0.05).141
5.2.6. Premature destruction of securin is not SCF
-TrCP-dependent.
Having shown that the premature destruction of securin in the absence of CDK1 and
MAPK activities could not be caused by APC/C
Cdc20 or APC/C
Cdh1, I went on to
investigate whether this effect was due to activation of the second major E3 ubiquitin
ligase, SCF (Skp1/Cullin/F-box protein). The possible involvement of SCF in the
premature destruction of securin was tested through inhibition of its activity, using the
dominant negative mutant of its F-box protein (-TrCP) (Guardavaccaro et al., 2003;
Marangos et al., 2007). The cRNA construct for the mutant -TrCP (-TrCP) was
microinjected in oocytes at GVBD, in order to avoid any interference with meiotic
resumption. These oocytes, alongside non-injected oocytes, were cultured for 5 h in the
presence or absence of roscovitine and UO126, and then assessed for their securin levels
using Western blotting. There was no significant difference in the levels of securin
between -TrCP-injected and non-injected MI oocytes (Fig. 5.6.A, B). More
importantly, the mutant in the inhibitor-treated oocytes failed to rescue securin levels,
which remained as low as those observed in the non-injected oocytes that were also
treated with roscovitine and UO126 (Fig. 5.6.A, B). These results suggest that the
targeted destruction of securin upon CDK1 and MAPK inhibition may not be SCF
-TrCP-
dependent.142
Fig. 5.6. Premature destruction of securin is not SCF
β -TrCP-dependent. (A) Western
blot of oocytes (n=20 per lane) for securin at MI, MI after treatment with roscovitine and
UO126 (R+U) and MI following microinjection with the cRNA for β-TrCP, in the
presence or absence of the inhibitors. All MI samples were collected at 5 h post release
from IBMX, and drugs treatment was performed between 3 and 5 h. Actin was used as a
loading control. (B) Densitometric analysis of Western blots from three independent
experiments. The results are mean ± s. d. MI is set at 100%. Asterisks indicate values
significantly different from control (MI value) at
*P (0.01-0.05), whereas NS represents
values not significantly different at
NSP > 0.05.143
5.3. Discussion
In meiosis, APC/C
Cdc20 ubiquitinates cyclin B1 and securin to induce anaphase onset and
chromosomes separation. More recently, it was shown that APC/C
Cdh1 is required for
maintaining the GV arrest by suppressing the levels of cyclin B1 (Marangos et al., 2007;
Reis et al., 2006a). Also, during prometaphase I, APC/C
Cdh1 targets Cdc20 for
destruction thereby delaying the onset of APC/C
Cdc20 activity and the onset of anaphase
(Reis et al., 2007). In contrast to mitosis, the meiotic mechanisms of APC/C regulation
are as yet unexplored, especially during the prolonged prometaphase I.
This study was set out to examine what causes the premature destruction of securin
during prometaphase I in the absence of MPF and MAPK activities. In the previous
chapter, I have demonstrated that securin stability is unlikely to be dependent on its
phosphorylation state, as determined by the mutagenesis experiments. Here, I found that
inhibition of both kinases also induces the premature degradation of other APC/C
substrates, suggesting that this effect might be due to activation of the APC/C.
Interestingly, only the D-box containing substrates, such as cyclin B1, geminin and wild
type securin were subject to destruction when MPF and MAPK were inhibited. The Ken-
box substrates, however, were not prematurely targeted for degradation. For example,
securin
DM, which only contains a functioning Ken-box, was stable throughout the cell
cycle and failed to be destroyed not only at the metaphase-to-anaphase transition, but also
during prometapahse I in the presence of MPF and MAPK inhibitors. These findings
further confirm the requirement of the D-box for the APC/C
Cdc20-mediated degradation of144
securin at the metaphase-to-anaphase transition, and also suggest its necessity for the
premature destruction of the APC/C substrates upon MPF and MAPK inhibition.
The targeted destruction of the D-box containing substrates and not Ken-box substrates
implies that APC/C
Cdc20 is a likely candidate for driving degradation in the absence of
MPF and MAPK activities. Surprisingly, examination of the levels of Cdc20 in the
presence of the inhibitors revealed that Cdc20 was also targeted for destruction,
suggesting that APC/C
Cdc20 is not responsible of the premature degradation of the D-box
substrates. This result, however, needs to be considered preliminary because due to
technical problems with the antibody, the Cdc20 Western was difficult to replicate. The
non-involvement of APC/C
Cdc20 in the premature destruction of the D-box substrates was
further confirmed by Cdc20-morpholino knockdown, which failed to rescue securin
stability upon MPF and MAPK inhibition.
It is well established that vertebrate Cdc20 does not contain a D-box, and in mammalian
oocytes APC/C
Cdh1 mediates its destruction through two independent degrons, the Ken-
box and CRY-box (Pfleger and Kirschner, 2000; Reis et al., 2006b). Also, in contrast to
Cdc20, the inhibition of MPF and MAPK stabilized the levels of Cdh1. Therefore, due to
the absence of the Cdh1 inhibitor, MPF, the high levels of Cdh1 may be responsible for
enhancing the prometaphase I activity of APC/C
Cdh1, thus making it capable of targeting
the destruction of other substrates rather than just Cdc20. Nevertheless, Cdh1
knockdown using antisense morpholino failed to rescue the premature destruction of145
securin upon MPF and MAPK inhibition, suggesting that this phenotype is not
APC/C
Cdh1-dependent.
Additionally, simultaneous knockdown of both Cdc20 and Cdh1 induced an increase in
the destruction of securin during prometaphase I in the presence and absence of MPF and
MAPK inhibitors. These results, further suggest that Cdc20 and Cdh1 may not be
necessary for the premature destruction of the D-box substrates upon MPF and MAPK
inhibition. There are a number of possible explanations for this unexpected result: (i)
another ubiquitin ligase may be active, (ii) the core APC/C may have upregulated acivity
and (iii) the existence of other APC/C co-activators, which may be meiosis-specific and
only become active when Cdh1 and Cdc20 are depleted.
Therefore, I turned to investigate the possible involvement of SCF (Skp1/Cullin/F-box
protein). SCF was chosen in particular because: (i) it is the second major E3 ubiquitin
ligase that is responsible of driving the meiotic cell cycle (Guardavaccaro et al., 2003);
(ii) its action is tightly coupled to the phosphorylation status of its substrates
(Guardavaccaro et al., 2003; Skowyra et al., 1997; Watanabe et al., 2004), and more
importantly (iii) it is active during early meiosis, when securin and the other D-box
substrates are targeted for destruction (Guardavaccaro et al., 2003; Marangos et al.,
2007). Interestingly, inhibition of SCF using the dominant negative mutant of its F-box
protein, -TrCP (Guardavaccaro et al., 2003; Marangos et al., 2007), also failed to
rescue the premature degradation of securin, indicating that this effect is not SCF
-TrCP-
dependent.146
Taken together, all these findings suggest that the instability of the D-box substrates upon
MPF and MAPK inhibition might well be due to activation of the APC/C independently
of its two major co-activators. However, it is not entirely clear how such activation may
take place. The core APC/C with APC10/Doc1 acting as a D-box receptor is one
possibility. Accordingly, it was recently reported that the D-box substrates could bind
directly to the core APC/C in the absence of Cdc20 and Cdh1 (Passmore et al., 2003;
Yamano et al., 2004). Such interaction is believed to be important in enhancing the
processivity of the D-box substrates ubiquitination through increasing the affinity of the
ligase towards its substrates (Carroll and Morgan, 2002). Also, it was found that
mutagenesis of APC10/Doc1, the only APC/C subunit thus far implicated as a D-box
receptor, not only decreases the binding of the D-box substrates to the APC/C in vitro,
but also reduces the efficiency of the ligase in targeting the destruction of its substrates in
vivo, thus delaying the mitotic cell cycle (Carroll et al., 2005).
Also, it is well established that the phosphorylation of the APC/C is required for its
activation and association with Cdc20, through which the ligase is mainly regulated
(Hershko et al., 1994; Kotani et al., 1998; Kraft et al., 2003). Therefore, it may be
possible that in the absence of MPF and MAPK activities, the lack of association with the
co-activator protein unleashes the core APC/C to target the destruction of the D-box
substrates. This may explain the increase in securin destruction when Cdc20 and Cdh1
were simultaneously depleted in the presence and absence of MPF and MAPK inhibitors.147
Alternatively, other APC/C co-activators, which are normally repressed by Cdh1 and
Cdc20, may be involved. Meiosis-specific activators have been identified in many other
organisms including yeast and flies (Asakawa et al., 2001; Blanco et al., 2001; Chu et al.,
2001; Cooper et al., 2000; Jacobs et al., 2002). These co-activators are expressed
exclusively during meiosis and have unique roles that are outside the functions of Cdc20
and Cdh1. In Drosphila, for example, the fizzy-like protein (cort) is only transcribed
during oogenesis, and its knockout results in eggs that are terminally arrested at Met II
(Chu et al., 2001; Lieberfarb et al., 1996; Page and OrrWeaver, 1996; Pesin and Orr-
Weaver, 2007). Although, cort is present throughout meiosis alongside Cdc20, it only
becomes active during meiosis II or meiosis I upon Cdc20 depletion (Pesin and Orr-
Weaver, 2007; Swan and Schupbach, 2007). This suggests that during meiosis I, the
activity of cort is some how repressed by Cdc20. Therefore, the same may be happening
in mouse oocytes. So, in the absence of MPF and MAPK activities, the lack of
phosphorylation of the APC/C and hence lack of association with Cdc20, may promote
its activation by another Cdc20-like activator, which targets the D-box substrates for
destruction by the proteasome.
In conclusion, the experiments reported here demonstrate that during prometaphase I,
either the activity of MPF or MAPK is required for inhibiting the premature onset of the
APC/C, thereby allowing the accumulation of the D-box containing substrates, such as
securin and cyclin B1. This is believed to be achieved through the recruitment of Cdc20,
which restrains the activity of the ligase during prometaphase through association with
different inhibitory proteins, such as Emi1 and the components of the SAC. So, in the148
absence of both MPF and MAPK activities, the APC/C is no longer phosphorylated and
unable to recruit Cdc20. The loss of Cdc20 may paradoxically lead to unrestrained
APC/C activity as a result of a loss of inhibition. However, it is not entirely clear how
this activation may take place. The core APC/C with APC10/Doc1 as a D-box receptor is
one possibility. Alternatively, this may be due to activation of some meiosis-specific
APC/C activators, which are normally repressed by Cdc20 and Cdh1 and become active
only when the two major co-activators are depleted.
Further work is needed to determine which, if any, of these mechanisms explains the
findings described above. In the future, I am planning on using the dominant negative
mutant of the APC10/Doc1 subunit to test if interfering with the binding of the D-box
substrates to the core APC/C would rescue the premature destruction of securin and the
other substrates upon MPF and MAPK inhibition. Additionally, It would be interesting
to examine if other meiosis-specific Cdc20-like co-activators exist in mouse oocytes and
if so their roles in controlling the meiotic cell cycle. It will also be important to
determine whether inhibition of MPF and MAPK induces the oocytes to arrest at Met I or
to exit the M-phase and enter interphase, given that those oocytes fail to extrude PB1
(data not shown). Finally, it will be crucial to establish if inhibition of both kinases also
induces premature separation of chromosomes via separase activation, since its two main
inhibitors (securin and cyclin B1) are targeted for destruction.149
Chapter 6: Conclusions
The main aim of the experiments presented in this thesis is to better understand how the
cell cycle is controlled during meiotic maturation of mouse oocytes. In what follows, I
will summarise and discuss the main findings of the thesis.
Mammalian oocytes enter the meiotic cell cycle during the female embryonic life and
become arrested in prophase of the first meiotic division for a period lasting from few
months (mice) to many years (humans), until sexual maturity (Alberts et al., 2000;
AUSTIN and Short, 1993; Bukovsky et al., 2005; Wolpert et al., 1998). At puberty and
under the influence of hormones, these prophase I-arrested oocytes resume the first
meiotic division, enter the second meiotic division and become arrested at the Met II
stage until fertilization (Yanagimachi, 1994). During metaphase II arrest, the egg has the
difficult task of ensuring the continued attachment of the sister chromatids, which is very
important because any premature loss of cohesion might lead to aneuploid embryos upon
fertilization of the egg by a sperm. The maintenance of the pairing of sister chromatids
during this period is achieved through inhibition of the cohesin-protease, separase.
In vertebrates, it is well established that separase is controlled by securin and MPF, which
are mutually exclusive at the molecular level, such that if one goes missing the other one
can compensate for it (Ciosk et al., 1998; Gorr et al., 2005; Petronczki et al., 2003; Zou et
al., 1999). Although, this mutuality has been proven in many systems including meiosis I
in mouse oocytes (Herbert et al., 2003; Petronczki et al., 2003). I found here that securin150
is the predominant inhibitor of separase during meiosis II (Chapter 3). Thus, inhibition
of CDK1 activity in Met II-arrested eggs using roscovitine failed to induce sister
chromatid separation, even though it induced cytokinesis and PB2 extrusion (Fig. 3.3).
Moreover, antibody inhibition of CDK1/cyclin B1 binding to separase also failed to
promote sister chromatid disjunction (Fig. 3.4). Instead, securin morpholino knockdown
induced sisters’ separation, which could be rescued by injection of securin cRNA (Fig.
3.5, 6).
Chromosomes segregation upon securin knockdown only occurred following PB1
extrusion and not during meiosis I (Fig. 3.5), which further confirms the mutuality of
securin and MPF activities during the first meiotic division. Therefore, it would be
interesting to investigate why such mutuality only exists during meiosis I and not meiosis
II, especially that securin levels at this stage are much lower than those observed during
meiosis I (Fig. 3.2). Thus, it will also be worth examining whether securin might have
other functions during the first meiotic division, when its levels are significantly high
(Fig. 3.2). Indeed, it was reported by Mrangos and Carroll (2008) that the high levels of
securin during prophase I arrest are important for preventing excessive loss of cyclin B1
and thus allowing progression through MI, by competing with cyclin B1 for APC
cdh1
binding sites (Marangos and Carroll, 2008).
Moreover, it will be crucial to investigate if the maintenance of securin levels present
problems for ageing eggs in keeping sister chromatids attachment, given that the maternal
age effect was proven to be stronger for meiosis II errors when compared to meiosis I151
non-disjunctions. For example, it was estimated by Yoon et al that the risk of MI errors
causing trisomy 21 increases by 10-fold when comparing 25 year-old women to women
over 40 years of age, whereas the same comparison for meiosis II errors shows a 60-fold
increase (Yoon et al., 1995).
Fig. 6.1. Mechanisms of separase regulation during meiosis I and II. During
meiosis I, early cleavage of cohesin and premature separation of chromosomes is
prevented by both MPF and securin, which play equal roles in inhibiting the protease
separase. During meiosis II, however, securin is the only inhibitor of separase.
Meiosis I
MPF/Securin Securin
Separase
Chromosomes disjunction
Cohesin Cleavage
Meiosis II152
As already mentioned in previous sections, securin is the best-known regulator of
separase and therefore it is highly regulated by mechanisms responding to cell cycle
progression. In addition to being expressed in a cell-cycle dependent manner, peaking in
M phase and getting destroyed at anaphase onset (Nabti et al., 2008; Ramos-Morales et
al., 2000), during the course of this study it has been reported that securin is subject to
another layer of regulation, phosphoryaltion (Holt et al., 2008). This was demonstrated
in yeast by Holt et al (2008), who found that securin stability during mitosis relies on its
phosphorylation by MPF near the D-box motif (Holt et al., 2008). Securin
phosphorylation was also observed upon entry into meiosis I in mouse oocytes (Chapter
4). This phosphorylation was proven to be catalysed by both MPF and MAPK (Fig. 4.2).
I also found that inhibition of these two kinases induces the premature destruction of
securin during proemetaphase of meiosis I (Fig. 4.2, 3). However, although these results
are consistent with earlier observation, this effect is not dependent on phosphorylation of
securin, given that mutagenesis of CDK1 and MAPK phosphorylation sites on securin
did not affect its stability (Fig. 4.5). Therefore, it would be worth examining the reasons
behind securin phosphorylation upon entry into meiosis I, other than regulating its
stability and function, given that securin mutagenesis also had no effect on securin’s
ability to inhibit separase (Fig. 4.6).
In a separate investigation, I found that CDK1 and MAPK inhibition also induces the
premature degradation of other APC/C substrates, such as cyclin B1 and geminin (Fig.
5.1). These findings suggest that this phenotype is not securin-specific and might be due
to a general activation of the APC/C, whose activity is well known to be modulated by its153
phosphorylation status (Hershko et al., 1994; Kotani et al., 1998; Kraft et al., 2003).
Interestingly, the D-box containing substrates only and not the Ken-box substrates were
subject to such effect (Fig. 5.1, 2), implying that APC/C
Cdc20 could be the mediator of this
phenotype. Surprisingly, the prometaphase I instability of the D-box substrates was
neither APC/C
Cdc20 nor APC/C
Cdh1-dependent, given that Cdc20 was also targeted for
destruction and morpholino-knockdown of Cdc20 and Cdh1 failed to rescue securin
stability (Fig. 5.3, 4). I also examined the possible involvement of the second major E3
ubiquitin ligase, SCF
β-TrCP. However, the inhibition of SCF using the dominant negative
mutant of its F-box protein (β-TrCP) could not restore securin levels, suggesting it is
not SCF
β-TrCP-dependent (Fig. 5.6).
Therefore, this effect could be attributed to activation of the APC/C independently of its
two known co-activators. It is well established that APC/C phosphorylation is required
for its activation and association with Cdc20, through which the ligase is mainly
regulated (Hershko et al., 1994; Kotani et al., 1998; Kraft et al., 2003). Therefore, it may
be possible that in the absence of MPF and MAPK activities, the lack of association with
the co-activator protein unleashes the APC/C to target the destruction of the D-box
substrates. However, it is not entirely clear how this activation may take place. The core
APC/C with APC10/Doc1 as a D-box receptor is one possibility (Fig. 6.2).
Alternatively, this may be due to activation of some meiosis-specific APC/C activators
(Fig. 6.2), which are normally repressed by Cdc20 and Cdh1, and become active only
when the two major co-activators are depleted.154
Future work is needed to determine which, if any, of these two hypotheses explains the
findings described above. Therefore, I am planning on genetically modifying the only
APC/C subunit thus far implicated as a D-box receptor (APC10/Doc1), and investigating
its effect on securin stability in the absence of MPF and MAPK activities. It will also be
crucial to test whether the recruitment of the co-activators by the APC/C restrains its
ligase activity from prematurely targeting the destruction of the D-box containing
substrates. Moreover, It would be interesting to examine whether other meiosis-specific
Cdc20-like co-activators exist in mouse oocytes and if so their roles in controlling the
meiotic cell cycle. Finally, it will be worth examining whether the sustained-high
activity of MAPK throughout the meiotic cell cycle plays any role in restraining the
activity of the APC/C when MPF activity is low during the cell cycle transitions.155
Fig. 6.2. The activity of MPF and MAPK is required for accumulation of the APC
D-box substrates during MI. (A) In the presence of MPF and MAPK, the APC
becomes phosphorylated, therefore promoting its association with Cdc20 and other
inhibitory factors, such as Emi1 and the components of SAC. Binding of the inhibitors to
APC/C
Cdc20 prevents it from becoming active and prematurely targeting the D-box
substrates for degradation. (B) In the absence of MPF and MAPK, the APC is no longer
phosphorylated and therefore incapable of recruiting Cdc20 and the inhibitors. As a
result, the APC becomes active and prematurely targets its D-box substrates for
destruction. The degradation of these substrates could be: (1) mediated by the core APC
with the APC10 subunit acting as a D-box receptor, or (2) through another co-activator,
which only binds to and activates the APC in the absence of MPF and MAPK.
A) Active MPF and MAPK
B) Inactive MPF and MAPK
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